Research Interests
Gastroenterology and HepatologyProf Jane Andrews
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Jane Andrews is Head of the IBD Service & Education at the Department of Gastroenterology & Hepatology of The Royal Adelaide Hospital in Australia and a Clinical Professor at the School of Medicine, University of Adelaide. Professor Andrews has a long clinical research interest and many years practical experience in managing both IBD and other luminal, especially functional, gastrointestinal disorders. She has an interest in clinical audit, value in care, clinical outcomes research and healthcare system delivery.
Professor Andrews is an active researcher in many aspects of clinical Gastroenterology. Particular interests include examining health access, models of care and equity issues in addition to optimising and auditing standard clinical management and trying to improve systems design. Whilst much of her research is focussed on IBD, she also has expertise in Functional GI disease and is also published in hepatology care especially with regard to psychological comorbidities and healthcare utilisation. Her current research collaborators include psychologists, mucosal immunologists, microbiologists, specialist IBD nurses, dietians and data scientists. Studies have included varying topics from Faecal Microbiota Transplantation, psychological care in IBD, new models of care for FGID, dietary issues in IBD to digital healthcare delivery (digital endoscopic service management, Surgical PreHab, IBD Consumer Co-care). She also collaborated nationally and internationally via membership of the ANZ IBD Consortium <www.ANZIBDC.org> and contributions to the international IBD Genetics Consortium. She is the board chair and medical director of the IBD-Specific charity, Crohn’s Colitis Cure <c-c-cure.org>.
Professor Andrews has authored several hundred publications, and has an H-Index of 58 (Research Gate). She has substantial experience with postgraduate medical education and higher degree supervision.
| Date | Position | Institution name |
|---|---|---|
| 2013 - ongoing | Clinical Professor | University of Adelaide |
| 2009 - 2013 | Clinical Ass Professor | University of Adelaide |
| 2009 - ongoing | Head IBD Service & Education | Royal Adelaide Hospital |
| 2007 - 2013 | Senior Consultant Gastroenterologist | Royal Adelaide Hospital |
| 2006 - 2013 | Senior Lecturer | Flinders University |
| 2002 - 2008 | Clinical Senior Lecturer | University of Adelaide |
| 2001 - 2002 | Senior Visiting Medical Specialist | Lyell McEwin Hospital |
| 2000 - 2007 | Senior Consultant Gastroenterologist | Repatriation General Hospital |
| 2000 - 2003 | Senior Research Fellow | University of Adelaide |
| 2000 - 2000 | Locum Senior Visiting Medical Specialist | Flinders Medical centre |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2012 | Award | SA Health Award for Improving Hospital Care - IBD Service RAH | SA Health | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 1995 - 2000 | University of Adelaide | Australia | PhD |
| 1994 | Royal Australasian College of Physicians | Australia | FRACP |
| 1986 | University of Sydney | Australia | MBBS 1st class Hons |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2009 | AGAF | American Gastroenterological Association | - |
| Year | Citation |
|---|---|
| 2025 | Goodsall, T. M., An, Y. K., Andrews, J. M., Begun, J., Friedman, A. B., Lee, A., . . . Bryant, R. V. (2025). Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central Reading. Clinical Gastroenterology and Hepatology, 23(9), 1600-1611.e9. Scopus7 WoS5 Europe PMC7 |
| 2025 | Karimi, N., Moore, A. R., Jones, A., Lukin, A., Pipicella, J. L., Williams, A. J., . . . Connor, S. J. (2025). On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease. Patient Education and Counseling, 130, 108487. Scopus2 Europe PMC1 |
| 2025 | McNamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Begun, J., Lawrance, I. C., . . . Connor, S. J. (2025). Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort. Gastro Hep Advances, 4(4), 4 pages. |
| 2025 | Kaazan, P., Charabaty, A., Yong, S., Andrews, J. M., Pathi, R., Heilbronn, L. K., . . . Barras, C. D. (2025). Small bowel imaging in Crohn’s disease with a special focus on obesity, pregnancy and postsurgical assessment. Frontline Gastroenterology, 16(4), 308-320. |
| 2025 | Abeyratne, K., Harb, M., Bensted, K., Ghaly, S., Connor, S. J., Andrews, J. M., & Lynch, K. D. (2025). Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas. Internal Medicine Journal, 55(3), 461-466. Scopus1 |
| 2025 | Pipicella, J. L., Dutt, S., Thacker, K., Connor, S. J., Andrews, J. M., & Vernon-Roberts, A. (2025). Crohn's Colitis Care, a Disease-Specific Electronic Medical Record, Enhances Data Capture in Pediatric Inflammatory Bowel Disease Care. Jgh Open, 9(5), 9 pages. |
| 2025 | Majstorovic, M., Chur-Hansen, A., Andrews, J., & Burke, A. L. J. (2025). On The Barriers and Enablers to Bariatric Surgery: A Qualitative Study with Bariatric Surgeons. Obesity Facts, 18(6), 1-16. |
| 2025 | Panaccione, R., Feagan, B. G., Afzali, A., Rubin, D. T., Reinisch, W., Panés, J., . . . Sands, B. E. (2025). Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials. Lancet, 406(10501), 358-375. Scopus7 WoS4 Europe PMC2 |
| 2025 | Day, A. S., Slater, R., Young, R. B., Wheeler, R. Z., Marcelino, V. R., Maddigan, N. K., . . . Bryant, R. V. (2025). Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis. Inflammatory Bowel Diseases, 31(11), 3160-3171. WoS1 |
| 2025 | Andrews, J. M. (2025). Prehabilitation for Inflammatory Bowel Disease Surgery. Gastroenterology and Hepatology, 21(9), 564-567. |
| 2025 | Evans, S., Naude, C., Coitinho Biurra, Y., Bowring, J., Knowles, S., Brooks, T., . . . Mikocka Walus, A. (2025). Online randomised e-hypnotherapy for chronic pelvic pain study (REST): comparing e-hypnotherapy with relaxation and waitlist to improve pain, cost-effectiveness and biopsychosocial outcomes. BMJ Open, 15(11), 1-10. |
| 2025 | An, Y. -K., Lindsay, N., Allan, N., Khoo, E., Fernandes, R., Gilmore, R., . . . Begun, J. (2025). Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.. JGH open : an open access journal of gastroenterology and hepatology, 9(12), e70322. |
| 2025 | Pipicella, J. L., Gu, B., McNamara, J., Wilson, W., Palmer, L. J., Connor, S. J., & Andrews, J. M. (2025). Proposal and exploration of a novel score to quantify patient-perceived burden of inflammatory bowel disease under routine care.. Intern Med J, 55(4), 589-598. |
| 2025 | Litwin, P., & Andrews, J. (2025). Benchmarking in inflammatory bowel disease: lessons from Australia and New Zealand. Journal of the Canadian Association of Gastroenterology, 8(Suppl 2), S21-S26. |
| 2024 | Majstorovic, M., Chur-Hansen, A., Burke, A. L. J., & Andrews, J. M. (2024). Bariatric surgeons' views on barriers and enablers to bariatric surgery in Australia and New Zealand: A qualitative content analysis.. Obesity Research and Clinical Practice, 18(6), 443-449. |
| 2024 | Barnes, A., Bryant, R. V., Mukherjee, S., Andrews, J. M., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach. Therapeutic Advances in Gastroenterology, 17, 12 pages. Scopus1 WoS1 Europe PMC2 |
| 2024 | Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intestinal Research, 22(1), 104-114. Scopus9 WoS11 Europe PMC9 |
| 2024 | Danese, S., Panaccione, R., Feagan, B. G., Afzali, A., Rubin, D. T., Sands, B. E., . . . D'Haens, G. R. (2024). Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. Lancet Gastroenterology and Hepatology, 9(2), 133-146. Scopus48 WoS48 Europe PMC37 |
| 2024 | Majstorovic, M., Chur-Hansen, A., Andrews, J. M., & Burke, A. (2024). Factors associated with progression or non-progression to bariatric surgery in adults: A systematic review. Obesity Reviews, 25(4), 11 pages. Scopus4 WoS4 Europe PMC4 |
| 2024 | Lores, T., Mikocka-Walus, A., Andrews, J. M., Evans, S., Lynch, K. D., & Chur-Hansen, A. (2024). Psychological Care for People with Inflammatory Bowel Diseases: Exploring Consumers' Perspectives to Inform Future Service Co-design. Digestive Diseases and Sciences, 69(6), 1979-1989. Scopus1 WoS1 Europe PMC1 |
| 2024 | Majstorovic, M., Chur-Hansen, A., Andrews, J. M., & Burke, A. L. J. (2024). Bariatric surgeons' views on pre-operative factors associated with improved health-related quality of life following surgery.. Clin Obes, 14(5), e12668. |
| 2024 | Barnes, A., Toson, B., Bryant, R. V., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Latent profiles of fatigue in inflammatory bowel disease. BMC Gastroenterology, 24(1), 7 pages. Scopus3 WoS3 Europe PMC3 |
| 2024 | Bills, E. R., Dimopoulos, A., Burke, A. L. J., Collins, K. L., Linedale, E. C., Hume, V., . . . Andrews, J. M. (2024). Opportunities to optimise care and choice in joint replacement surgery using a digitally delivered, holistic PreHab pathway. Journal of Orthopaedic Surgery, 32(2), 13 pages. Scopus1 |
| 2024 | Barnes, A., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Active Inflammatory Bowel Disease Is Associated with Short Sleep Duration via Objective Measures. Digestive Diseases and Sciences, 69(8), 2937-2943. |
| 2024 | Little, R. D., McKenzie, J., Srinivasan, A., Hilley, P., Gilmore, R. B., Chee, D., . . . Sparrow, M. P. (2024). Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial. BMJ Open, 14(7), 8 pages. Scopus3 WoS3 Europe PMC4 |
| 2023 | McNamara, J., Connor, S. J., & Andrews, J. M. (2023). The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform. Inflammatory Bowel Diseases, 29(9), 1510-1511. Scopus1 WoS1 Europe PMC2 |
| 2023 | Lores, T., Evans, S., Chur-Hansen, A., Andrews, J. M., Goess, C., Smith, L., . . . Mikocka-Walus, A. A. (2023). Virtual adjunctive gut-directed hypnotherapy for people with Crohn's disease: A randomized controlled pilot and feasibility trial.. Complement Ther Clin Pract, 53, 1-9. Scopus5 WoS4 Europe PMC5 |
| 2023 | Baumdick, M. E., Niehrs, A., Degenhardt, F., Schwerk, M., Hinrichs, O., Jordan-Paiz, A., . . . Festen, E. A. (2023). HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis. Gastroenterology, 165(4), 946-962.e13. Scopus14 Europe PMC11 |
| 2023 | Pipicella, J. L., Vernon-Roberts, A., Dutt, S., Giles, E., Day, A. S., Connor, S. J., & Andrews, J. M. (2023). Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease. Digestive Diseases and Sciences, 68(12), 4368-4380. Scopus3 WoS3 Europe PMC2 |
| 2023 | Akhlaghpour, M., Haritunians, T., More, S. K., Thomas, L. S., Stamps, D. T., Dube, S., . . . Michelsen, K. S. (2023). Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut, 72(11), 2068-2080. Scopus12 Europe PMC10 |
| 2023 | Tye-Din, J. A., Daveson, A. J. M., Goel, G., Goldstein, K. E., Hand, H. L., Neff, K. M., . . . Wilson, S. A. (2023). Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. Lancet Gastroenterology and Hepatology, 8(5), 446-457. Scopus29 Europe PMC20 |
| 2023 | Linedale, E. C., Bills, E., Dimopoulos, A., Yeoh, J., Nolan, M., Hume, V., . . . Andrews, J. M. (2023). Development of a feasible and acceptable digital prehabilitation pathway to improve elective surgical outcomes. Frontiers in Digital Health, 5, 10 pages. Scopus4 WoS3 Europe PMC3 |
| 2023 | Louis, E., Resche-Rigon, M., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., . . . Roblin, X. (2023). Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet Gastroenterology and Hepatology, 8(3), 215-227. Scopus89 Europe PMC69 |
| 2023 | Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Spizzo, P., . . . Mountifield, R. (2023). Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease. Crohn S and Colitis 360, 5(2), 8 pages. Scopus3 WoS3 Europe PMC3 |
| 2023 | Lores, T., Krishnaprasad, K., Connor, S. J., Cabaero, A., & Andrews, J. M. (2023). Integration of mental health and quality of life screening tools in an inflammatory bowel disease-specific electronic medical record (Crohn Colitis Care): process and early outcomes. Internal Medicine Journal, 53(1), 136-139. Scopus4 Europe PMC3 |
| 2023 | Barnes, A., Spizzo, P., Bampton, P., Andrews, J. M., Fraser, R. J., Mukherjee, S., & Mountifield, R. (2023). Examining the influence of inflammatory bowel disease medications on sleep quality. Jgh Open, 7(3), 190-196. Scopus6 WoS3 Europe PMC2 |
| 2023 | Burisch, J., Zhao, M., Odes, S., De Cruz, P., Vermeire, S., Bernstein, C. N., . . . Munkholm, P. (2023). The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterology and Hepatology, 8(5), 458-492. Scopus144 WoS131 Europe PMC117 |
| 2023 | Barnes, A., Ooi, S. Y. J., Lynch, K. D., Parthasarathy, N., Bishara, M., Gounder, M., . . . Andrews, J. M. (2023). Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 68(3), 889-896. Scopus4 WoS3 Europe PMC3 |
| 2023 | Young, E., Jones, E., Thomas, M., Lawrence, M., & Andrews, J. (2023). Poor engagement and adherence predict neoplasia in inflammatory bowel disease: a case-control study. Internal Medicine Journal, 53(5), 731-737. |
| 2023 | Lanas, A., Andrews, J. M., Lau, J., Toruner, M., Bromley, S. E., & Gralnek, I. M. (2023). Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review. Journal of Gastroenterology and Hepatology Australia, 38(1), 23-33. Scopus8 WoS7 Europe PMC8 |
| 2022 | Guzzo, G. L., Mittinty, M. N., Llamas, B., Andrews, J. M., & Weyrich, L. S. (2022). Individuals with Inflammatory Bowel Disease Have an Altered Gut Microbiome Composition of Fungi and Protozoa. Microorganisms, 10(10), 1910. Scopus14 WoS11 Europe PMC10 |
| 2022 | Mortlock, S., Lord, A., Montgomery, G., Zakrzewski, M., Simms, L. A., Krishnaprasad, K., . . . Radford-Smith, G. L. (2022). An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis, 17(2), 277-288. Scopus8 WoS8 Europe PMC6 |
| 2022 | Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., McIvor, C., & Andrews, J. M. (2022). Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.. Digestive diseases and sciences, 67(12), 5628-5636. Scopus11 WoS10 Europe PMC9 |
| 2022 | Day, A. S., Yao, C. K., Costello, S. P., Ruszkiewicz, A., Andrews, J. M., Gibson, P. R., & Bryant, R. V. (2022). Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. Journal of Nutrition, 152(7), 1690-1701. Scopus34 WoS34 Europe PMC29 |
| 2022 | Duong, T. A., Bryant, R. V., Andrews, J. M., & Lynch, K. D. (2022). Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease. Internal Medicine Journal, 52(6), 1070-1074. Scopus5 WoS5 Europe PMC5 |
| 2022 | Rubin, D. T., Dotan, I., DuVall, A., Bouhnik, Y., Radford-Smith, G., Higgins, P. D. R., . . . Gonciarz, M. (2022). Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. Lancet Gastroenterology and Hepatology, 7(1), 17-27. Scopus80 Europe PMC69 |
| 2022 | Lores, T., & Andrews, J. M. (2022). Routine psychological assessment in inflammatory bowel disease management: practice beyond novelty. Internal Medicine Journal, 52(1), 156-157. |
| 2022 | Guzzo, G. L., Andrews, J. M., & Weyrich, L. S. (2022). The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.. Inflamm Bowel Dis, 28(7), 1112-1122. Scopus44 WoS39 Europe PMC34 |
| 2022 | Sandborn, W. J., D'Haens, G. R., Reinisch, W., Panés, J., Chan, D., Gonzalez, S., . . . Feagan, B. G. (2022). Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162(6), 1650-1664.e8. Scopus171 WoS167 Europe PMC135 |
| 2022 | Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2022). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 35(1), 234-244. Scopus36 WoS32 Europe PMC32 |
| 2022 | Liu, Z., Julsgaard, M., Zhu, X., Martin, J., Barclay, M. L., Cranswick, N., . . . Ellard, K. (2022). Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children. Journal of Crohn S and Colitis, 16(12), 1835-1844. Scopus16 Europe PMC14 |
| 2022 | Barnes, A., Mountifield, R., Baker, J., Spizzo, P., Bampton, P., Andrews, J. M., . . . Mukherjee, S. (2022). A systematic review and meta-analysis of the prevalence of poor sleep in inflammatory bowel disease.. Sleep advances : a journal of the Sleep Research Society, 3(1), 1-10. Scopus20 Europe PMC18 |
| 2021 | Gu, B., De Gregorio, M., Pipicella, J. L., Vande Casteele, N., Andrews, J. M., Begun, J., . . . Connor, S. (2021). Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol.. BMJ open, 11(7), e043921. Scopus12 WoS11 Europe PMC9 |
| 2021 | Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 16 pages. Scopus74 WoS68 Europe PMC63 |
| 2021 | Wu, Y., Wen, A., Selvanderan, S. P., Xuan, W., Andrews, J. M., Koo, J. H., . . . Connor, S. (2021). Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels. Crohn S and Colitis 360, 3(3), 7 pages. Scopus1 WoS1 Europe PMC1 |
| 2021 | Kariyawasam, V. C., Mourad, F. H., Mitrev, N., Paramsothy, S., Selinger, C. P., Katelaris, P. H., . . . Leong, R. W. (2021). Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis. European Journal of Gastroenterology and Hepatology, 33(12), 1524-1532. Scopus8 Europe PMC5 |
| 2021 | Barnes, A., Andrews, J., Spizzo, P., & Mountifield, R. (2021). Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic. Jgh Open, 5(5), 585-589. Scopus13 WoS12 Europe PMC15 |
| 2021 | Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142. Scopus69 WoS62 Europe PMC55 |
| 2021 | Sammour, T., Schoeman, M., Moore, J. W., Thomas, M. L., Moorcraft, L., & Andrews, J. M. (2021). Clearing a colonoscopy waiting list: how we did it. ANZ J Surg, 91(1-2), 10-12. Scopus1 Europe PMC1 |
| 2021 | Kim, A. H., Girgis, A., De Cruz, P., Siegel, C. A., Karimi, N., Ruban, S. O., . . . Connor, S. J. (2021). Development and feasibility of a web-based decision aid for patients with ulcerative colitis: Qualitative pilot study. Journal of Medical Internet Research, 23(2), 17 pages. Scopus18 WoS14 Europe PMC12 |
| 2021 | Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3. Scopus33 WoS27 Europe PMC21 |
| 2021 | Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.. Journal of Human Nutrition and Dietetics, 34(2), 420-428. Scopus20 WoS19 Europe PMC15 |
| 2020 | Mikocka-Walus, A., Massuger, W., Knowles, S. R., Moore, G. T., Buckton, S., Connell, W., . . . Andrews, J. M. (2020). Quality of Care in Inflammatory Bowel Disease: Actual Health Service Experiences Fall Short of the Standards.. Internal medicine journal, 50(10), 1216-1225. Scopus26 WoS30 Europe PMC30 |
| 2020 | Daveson, A. J. M., Tye-Din, J. A., Goel, G., Goldstein, K. E., Hand, H. L., Neff, K. M., . . . Wilson, S. (2020). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology and Therapeutics, 51(2), 244-252. Scopus41 Europe PMC32 |
| 2020 | Bedrikovetski, S., Liu, J., Dudi Venkata, N. N., Kroon, H., Lewis, M., Lawrence, M., . . . Sammour, T. (2020). Rectal Stump Management After Subtotal Colectomy for Severe Colitis, In or Out? A Retrospective Cohort Study. Indian Journal of Surgery, 82(4), 585-591. |
| 2020 | Kaazan, P., Tan, Z., Bednarz, J., Hughes, J., Grafton, R., & Andrews, J. M. (2020). Infliximab-related weight gain in inflammatory bowel disease: associations and financial impacts. Internal medicine journal, 50(9), 1134-1138. Scopus3 WoS3 Europe PMC3 |
| 2020 | Flanagan, E., Gibson, P. R., Wright, E. K., Moore, G. T., Sparrow, M. P., Connell, W., . . . Bell, S. J. (2020). Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 52(10), 1551-1562. Scopus49 Europe PMC40 |
| 2020 | Krishnaprasad, K., Walsh, A., Begun, J., Bell, S., Carter, D., Grafton, R., . . . Andrews, J. M. (2020). Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 55(12), 1419-1426. Scopus23 WoS23 Europe PMC16 |
| 2020 | Tye-Din, J. A., Daveson, A. J. M., Goldstein, K. E., Hand, H. L., Neff, K. M., Goel, G., . . . Wilson, S. (2020). Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC Medicine, 18(1), 362. Scopus39 Europe PMC31 |
| 2020 | Shaikh, A., & Andrews, J. (2020). Is it IBD? Making an accurate and prompt diagnosis. Medicine Today, 21(12), 28-33. |
| 2020 | Kaazan, P., Li, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2020). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. JGH Open, 5(9), 1063-1070. Scopus7 WoS7 Europe PMC6 |
| 2020 | Kim, A. H., Girgis, A., Karimi, N., Sechi, A. J., Descallar, J., Andrews, J. M., . . . Connor, S. J. (2020). A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients with ulcerative colitis: Protocol for a cluster randomized controlled trial. Jmir Research Protocols, 9(7), 12 pages. Scopus11 WoS10 Europe PMC7 |
| 2020 | Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Begun, J., Keung, C., . . . Lawrance, I. C. (2020). Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford. WORLD JOURNAL OF GASTROENTEROLOGY, 26(30), 4428-4441. Scopus19 WoS20 Europe PMC16 |
| 2020 | Hamarneh, Z., Robinson, K., Andrews, J., Hunt, R., & Fraser, R. (2020). Transfusion strategies in upper gastrointestinal bleeding management: a review of South Australian hospital practice. Internal Medicine Journal, 50(5), 582-589. Scopus1 Europe PMC1 |
| 2020 | Gardiner, F. W., Bishop, L., McMahon, K., Nwose, E. U., Connor, S., Begun, J., & Andrews, J. M. (2020). Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice. Internal Medicine Journal, 50(5), 619-623. Scopus1 |
| 2020 | Lores, T., Goess, C., Mikocka-Walus, A., Collins, K., Burke, A. L. J., Chur-Hansen, A., . . . Andrews, J. (2020). Integrated Psychological Care Reduces Healthcare Costs at a Hospital-Based Inflammatory Bowel Disease Service. Clinical Gastroenterology and Hepatology, 19(1), 96-103. Scopus71 WoS66 Europe PMC51 |
| 2020 | Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D., Papanicolas, L. E., McKew, G. L., . . . Leong, R. W. (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.. Gut, 69(5), 801-810. Scopus78 WoS69 Europe PMC61 |
| 2020 | Mikocka-Walus, A., Massuger, W., Knowles, S. R., Moore, G. T., Buckton, S., Connell, W., . . . Andrews, J. M. (2020). Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. Jgh Open, 4(2), 166-171. Scopus44 WoS39 Europe PMC32 |
| 2020 | Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., . . . Bell, S. J. (2020). Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.. Inflammatory bowel diseases, 26(1), 93-102. Scopus33 WoS32 Europe PMC26 |
| 2020 | Linedale, E. C., Mikocka-Walus, A., Gibson, P. R., & Andrews, J. M. (2020). The potential of integrated nurse-led models to improve care for people with functional gastrointestinal disorders: A systematic review. Gastroenterology Nursing, 43(1), 53-64. Scopus10 WoS8 Europe PMC11 |
| 2019 | Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600. Scopus61 WoS58 Europe PMC52 |
| 2019 | Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63. |
| 2019 | Mikocka-Walus, A., Prady, S., Pollok, J., Esterman, A., Gordon, A. L., Knowles, S., & Andrews, J. (2019). Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews, 2019(4, article no. CD012680), 1-52. Scopus3 WoS47 Europe PMC33 |
| 2019 | Costello, S. P., Conlon, M. A., & Andrews, J. M. (2019). Fecal microbiota transplantation for ulcerative colitis-Reply. JAMA Journal of the American Medical Association, 321(22), 2240-2241. Scopus7 WoS7 Europe PMC8 |
| 2019 | Bedrikovetski, S., Dudi Venkata, N., Kroon, H. M., Liu, J., Andrews, J. M., Lewis, M., . . . Sammour, T. (2019). Systematic review of rectal stump management during and after emergency total colectomy for acute severe ulcerative colitis. ANZ J Surg, 89(12), 1556-1560. Scopus15 WoS10 Europe PMC8 |
| 2019 | Kariyawasam, V. C., Kim, S., Mourad, F. H., Selinger, C. P., Katelaris, P. H., Brian Jones, D., . . . Leong, R. W. (2019). Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.. Inflammatory bowel diseases, 25(8), 1390-1398. Scopus24 Europe PMC16 |
| 2019 | Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., . . . Andrews, J. M. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164. Scopus752 WoS678 Europe PMC589 |
| 2019 | Lores, T., Goess, C., Mikocka-Walus, A., Collins, K. L., Burke, A. L. J., Chur-Hansen, A., . . . Andrews, J. M. (2019). Integrated psychological care is needed, welcomed and effective in ambulatory Inflammatory Bowel Disease management: Evaluation of a new initiative.. Journal of Crohn's & colitis, 13(7), 819-827. Scopus58 WoS53 Europe PMC46 |
| 2019 | Walker, G. J., Harrison, J. W., Heap, G. A., Voskuil, M. D., Andersen, V., Anderson, C. A., . . . Gee, I. (2019). Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease. JAMA Journal of the American Medical Association, 321(8), 753-761. Scopus142 WoS139 Europe PMC125 |
| 2019 | Massuger, W., Moore, G. T. C., Andrews, J. M., Kilkenny, M. F., Reyneke, M., Knowles, S., . . . Pavli, P. (2019). Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.. Internal medicine journal, 49(7), 859-866. Scopus46 WoS46 Europe PMC39 |
| 2019 | Romagnoni, A., Jégou, S., Van Steen, K., Wainrib, G., Hugot, J. P., Peyrin-Biroulet, L., . . . Sharma, Y. (2019). Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports, 9(1), 18 pages. Scopus88 WoS81 Europe PMC62 |
| 2019 | Young, E., Lawrence, M., Thomas, M., & Andrews, J. (2019). Gastrointestinal neoplasia in patients with inflammatory bowel disease: Opportunities to enhance preventative strategies. Jgh Open, 3(6), 513-517. Scopus2 WoS2 Europe PMC1 |
| 2019 | An, Y. -K., Prince, D., Gardiner, F., Neeman, T., Linedale, E. C., Andrews, J. M., . . . Begun, J. (2019). Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.. The Medical journal of Australia, 211(10), 7 pages. Scopus22 WoS20 Europe PMC13 |
| 2019 | Liu, J., Andrews, J. M., Sammour, T., Bryant, R. V., Grafton, R., Simpson, E., . . . Nixon, C. (2019). Benefits of exclusive enteral nutrition in adults with complex active Crohn's disease: A case series of 13 consecutive patients. Crohn's and Colitis 360, 1(3), 1-7. Scopus4 WoS3 |
| 2018 | Rivas, M. A., Avila, B. E., Koskela, J., Huang, H., Stevens, C., Pirinen, M., . . . Gearry, R. (2018). Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. Plos Genetics, 14(5), e1007329. Scopus64 Europe PMC67 |
| 2018 | Mikocka-Walus, A., & Andrews, J. M. (2018). It is high time to examine the psyche while treating IBD. Nature Reviews Gastroenterology and Hepatology, 15(6), 329-330. Scopus22 WoS19 Europe PMC16 |
| 2018 | Linedale, E., Mikocka-Walus, A., Vincent, A., Gibson, P., & Andrews, J. (2018). Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial. Neurogastroenterology and Motility, 30(1), e13243-1-e13243-10. Scopus8 WoS10 Europe PMC8 |
| 2018 | Knowles, S., Andrews, J. M., & Porter, A. (2018). Predictors of Impaired Mental Health and Support Seeking in Adults With Inflammatory Bowel Disease: An Online Survey.. Gastroenterol Nurs, 41(1), 38-46. Scopus15 Europe PMC15 |
| 2018 | Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Selvaraj, F., Princen, F., . . . Connell, W. (2018). Anti-TNF therapeutic drug monitoring in postoperative Crohn's disease. Journal of Crohn's and Colitis, 12(6), 653-661. Scopus24 WoS25 Europe PMC19 |
| 2018 | Flanagan, E., Gibson, P. R., Begun, J., Ghaly, S., Garg, M., Andrews, J. M., . . . Bell, S. J. (2018). Letter: vedolizumab drug concentrations in neonates following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 48(11-12), 1328-1330. Scopus15 Europe PMC11 |
| 2018 | Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17. Scopus65 WoS64 Europe PMC51 |
| 2018 | Ferman, M., Lim, A. H., Hossain, M., Siow, G. W., & Andrews, J. M. (2018). Multidisciplinary team meetings appear to be effective in inflammatory bowel disease management: an audit of process and outcomes. Internal Medicine Journal, 48(9), 1102-1108. Scopus35 WoS32 Europe PMC30 |
| 2018 | Roberts, R. L., Wallace, M. C., Seinen, M. L., van Bodegraven, A. A., Krishnaprasad, K., Jones, G. T., . . . Barclay, M. L. (2018). Nonsynonymous polymorphism in guanine monophosphate synthetase is a risk factor for unfavorable thiopurine metabolite ratios in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 24(12), 2606-2612. Scopus7 WoS8 Europe PMC4 |
| 2018 | Momozawa, Y., Dmitrieva, J., Théâtre, E., Deffontaine, V., Rahmouni, S., Charloteaux, B., . . . Huang, H. (2018). IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications, 9(1), 18 pages. Scopus164 WoS169 Europe PMC167 |
| 2018 | Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607. Scopus41 WoS37 Europe PMC34 |
| 2018 | Mavrangelos, C., Campaniello, M., Andrews, J., Bampton, P., & Hughes, P. (2018). Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome. Gut, 67(2), 398-399. Scopus7 WoS7 Europe PMC6 |
| 2017 | Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224. Scopus229 WoS208 Europe PMC184 |
| 2017 | Andrews, J. M. (2017). Editorial: yoga for QoL in ulcerative colitis—any better than other supportive activities?. Alimentary Pharmacology and Therapeutics, 46(2), 201-202. Scopus2 Europe PMC1 |
| 2017 | Mikocka Walus, A., Fielder, A., Prady, S. L., Esterman, A. J., Knowles, S., & Andrews, J. M. (2017). Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane database of systematic reviews, 2017(7, article no. CD012680), 1-12. Scopus54 |
| 2017 | Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632. |
| 2017 | Chen, G., Lee, S., Montgomery, G., Wray, N., Visscher, P., Gearry, R., . . . Moser, G. (2017). Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Medical Genetics, 18(1), 94-1-94-11. Scopus39 WoS37 Europe PMC28 |
| 2017 | Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053. Scopus266 WoS231 Europe PMC193 |
| 2017 | Linedale, E. C., & Andrews, J. M. (2017). Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Medical Journal of Australia, 207(7), 309-315. Scopus24 WoS15 Europe PMC14 |
| 2017 | Linedale, E. C., Shahzad, M. A., Kellie, A. R., Mikocka-Walus, A., Gibson, P. R., & Andrews, J. M. (2017). Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders. JGH Open, 1(3), 84-91. Scopus13 WoS14 Europe PMC12 |
| 2017 | Shah, A., Talley, N., Walker, M., Koloski, N., Morrison, M., Burger, D., . . . Holtmann, G. (2017). Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?. Digestive Diseases and Sciences, 62(9), 2472-2480. Scopus13 WoS11 Europe PMC8 |
| 2017 | Lawrance, I., Baird, A., Lightower, D., Radford-Smith, G., Andrews, J., & Connor, S. (2017). Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. Clinical Gastroenterology and Hepatology, 15(8), 1248-1255. Scopus60 WoS49 Europe PMC39 |
| 2017 | Bye, W. A., Sparrow, M. P., Connor, S. J., Andrews, J. M., Ellard, K., Ng, W., . . . Walsh, A. J. (2017). The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus. Internal Medicine Journal, 47(11), 1263-1269. Scopus3 WoS2 Europe PMC2 |
| 2017 | Fazal, M., Andrews, J., Thomas, J., & Saffouri, E. (2017). Inpatient iron deficiency detection and management: how do general physicians and gastroenterologists perform in a tertiary care hospital?. Internal Medicine Journal, 47(8), 928-932. Scopus2 WoS3 Europe PMC2 |
| 2017 | Ben-Horin, S., Andrews, J., Katsanos, K., Rieder, F., Steinwurz, F., Karmiris, K., . . . Bernstein, C. (2017). Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice. World Journal of Gastroenterology, 23(16), 2995-3002. Scopus8 WoS9 Europe PMC8 |
| 2017 | Doecke, J., Hartnell, F., Bampton, P., Bell, S., Mahy, G., Grover, Z., . . . Radford-Smith, G. (2017). Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study. Alimentary Pharmacology and Therapeutics, 45(4), 542-552. Scopus39 Europe PMC35 |
| 2017 | Daveson, A. J. M., Ee, H. C., Andrews, J. M., King, T., Goldstein, K. E., Dzuris, J. L., . . . Anderson, R. P. (2017). Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. Ebiomedicine, 26, 78-90. Scopus60 Europe PMC40 |
| 2017 | Goel, G., King, T., Daveson, A. J., Andrews, J. M., Krishnarajah, J., Krause, R., . . . Anderson, R. P. (2017). Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterology and Hepatology, 2(7), 479-493. Scopus134 Europe PMC95 |
| 2017 | Bryant, R. V., Costello, S. P., Tee, D., Mountifield, R., Schoeman, S., Schoeman, M., . . . Andrews, J. M. (2017). TREAT TO TARGET: RECOMMENDATIONS IN ULCERATIVE COLITIS (UC) IN PRACTICE: CLINICIAN PERCEPTIONS AND POTENTIAL BARRIERS. GASTROENTEROLOGY, 152(5), S772. |
| 2017 | Mikocka-Walus, A., Hughes, P. A., Bampton, P., Gordon, A., Campaniello, M. A., Mavrangelos, C., . . . Andrews, J. M. (2017). Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomised placebo-controlled trial. Journal of Crohn's & colitis, 11(4), 509-514. Scopus50 WoS50 Europe PMC41 |
| 2017 | Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2017). Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial. International Journal of Behavioral Medicine, 24(1), 127-135. Scopus63 WoS64 Europe PMC55 |
| 2017 | Hamilton, A., Kamm, M., De Cruz, P., Wright, E., Selvaraj, F., Princen, F., . . . Connell, W. (2017). Serologic antibodies in relation to outcome in postoperative Crohn's disease. Journal of Gastroenterology and Hepatology, 32(6), 1195-1203. Scopus28 WoS24 Europe PMC21 |
| 2017 | Hillock, N. T., Heard, S., Kichenadasse, G., Hill, C. L., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290. Scopus38 WoS32 Europe PMC24 |
| 2016 | Hsieh, A. H. C., Ferman, M., Brown, M. P., & Andrews, J. M. (2016). Vedolizumab: a novel treatment for ipilimumab-induced colitis. BMJ Case Reports, 2016, bcr2016216641-1-bcr2016216641-4. Scopus50 Europe PMC40 |
| 2016 | An, V., Cohen, L., Lawrence, M., Thomas, M., Andrews, J., & Moore, J. (2016). Early surgery in Crohn's disease a benefit in selected cases.. World journal of gastrointestinal surgery, 8(7), 492-500. Europe PMC29 |
| 2016 | Andrews, J. M., Costello, S. P., Agarwal, A. K., Bampton, P., Beswick, L., Connor, S., . . . Walsh, A. J. (2016). Conflict of interest: Real and perceived - a more mature consideration is needed. Internal Medicine Journal, 46(3), 377-379. |
| 2016 | Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513. Scopus24 WoS18 Europe PMC16 |
| 2016 | McCallum, S., Andrews, J., Gaughwin, M., Turnbull, D., & Mikocka-Walus, A. (2016). Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms. Patient Preference and Adherence, 10, 1489-1500. Scopus10 WoS10 Europe PMC8 |
| 2016 | Linedale, E., Chur-Hansen, A., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2016). Uncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disorders. Clinical Gastroenterology and Hepatology, 14(12), 1735-1741.e1. Scopus30 WoS26 Europe PMC27 |
| 2016 | Bodea, C. A., Neale, B. M., Ripke, S., Barclay, M., Peyrin-Biroulet, L., Chamaillard, M., . . . Zhao, H. (2016). A method to exploit the structure of genetic ancestry space to enhance case-control studies. American Journal of Human Genetics, 98(5), 857-868. Scopus13 Europe PMC17 |
| 2016 | Elnawsra, O., Fok, I., Sparrow, M., Gibson, P., Andrews, J., & Connor, S. (2016). Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists. Internal Medicine Journal, 46(5), 590-595. Scopus7 WoS5 Europe PMC4 |
| 2016 | Chen, J. H., Andrews, J. M., Kariyawasam, V., Moran, N., Gounder, P., Collins, G., . . . Leong, R. W. (2016). Review article: Acute severe ulcerative colitis - Evidence-based consensus statements. Alimentary Pharmacology and Therapeutics, 44(2), 127-144. Scopus75 WoS68 Europe PMC57 |
| 2016 | Mikocka-Walus, A., & Andrews, J. (2016). Experience with and attitudes toward psychotherapy and antidepressants among patients with inflammatory bowel disease and functional gastrointestinal disorders. Gastroenterology Nursing, 39(4), 278-286. Scopus8 WoS7 Europe PMC5 |
| 2016 | Andrews, J. M. (2016). Barriers to reforming low-value care. Medical Journal of Australia, 204(5), 187-1e1. Scopus1 Europe PMC1 |
| 2016 | Costello, S., Tucker, E., La Brooy, J., Schoeman, M., & Andrews, J. (2016). Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clinical Infectious Diseases, 62(7), 908-914. Scopus98 WoS92 Europe PMC79 |
| 2016 | Mikocka-Walus, A., Andrews, J. M., & Bampton, P. (2016). Cognitive behavioral therapy for IBD. Inflammatory Bowel Diseases, 22(2), E5-E6. Scopus12 WoS9 Europe PMC10 |
| 2016 | Bennett, A. L., Moore, D., Bampton, P. A., Bryant, R. V., & Andrews, J. M. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620. Scopus40 WoS37 Europe PMC29 |
| 2016 | Bennett, A. L., Buckton, S., Lawrance, I., Leong, R. W., Moore, G., & Andrews, J. M. (2016). Ulcerative colitis outpatient management: development and evaluation of tools to support primary care practitioners (vol 45, pg 1254, 2015). INTERNAL MEDICINE JOURNAL, 46(2), 244. |
| 2016 | Julsgaard, M., Christensen, L., Gibson, P., Gearry, R., Fallingborg, J., Hvas, C., . . . Bell, S. (2016). Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology, 151(1), 110-119. Scopus290 WoS256 Europe PMC212 |
| 2016 | Cleynen, I., Boucher, G., Jostins, L., Schumm, L., Zeissig, S., Ahmad, T., . . . Lees, C. (2016). Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet, 387(10014), 156-167. Scopus658 WoS591 Europe PMC530 |
| 2016 | Andrews, J. M. (2016). How to fund IBD nurses. Journal of Gastroenterology and Hepatology Australia, 31(S1), 43. Scopus3 Europe PMC3 |
| 2016 | Williamson, K., Gill, M., Andrews, J., & Harley, H. (2016). Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?. Internal Medicine Journal, 46(12), 1407-1413. Scopus4 WoS4 Europe PMC3 |
| 2016 | Mikocka-Walus, A., Ahl, A., Gordon, A., & Andrews, J. (2016). A cognitive behavioural therapy booklet for anxiety in functional gastrointestinal disorders: patient and health practitioner perspectives. Psychotherapy Research, 26(2), 164-177. Scopus3 WoS3 Europe PMC1 |
| 2016 | Mccallum, S., Mikocka-Walus, A., Gaughwin, M., Andrews, J., & Turnbull, D. (2016). 'I'm a sick person, not a bad person': Patient experiences of treatments for alcohol use disorders. Health Expectations, 19(4), 828-841. Scopus31 WoS28 Europe PMC22 |
| 2016 | McCombie, A., Gearry, R., Andrews, J., Mulder, R., & Mikocka-Walus, A. (2016). Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflammatory Bowel Diseases, 22(1), 171-181. Scopus75 WoS69 Europe PMC59 |
| 2015 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., . . . Desmond, P. V. (2015). Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis. Alimentary Pharmacology and Therapeutics, 42(7), 867-879. Scopus121 WoS111 Europe PMC86 |
| 2015 | Costello, S., Conlon, M., Vuaran, M., Roberts-Thomson, I., & Andrews, J. (2015). Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: Clinical efficacy and bacterial viability data. Alimentary Pharmacology and Therapeutics, 42(8), 1011-1018. Scopus124 WoS113 Europe PMC106 |
| 2015 | Bennett, A., Buckton, S., Lawrance, I., Leong, R., Moore, G., & Andrews, J. (2015). Ulcerative colitis outpatient management: Development and evaluation of tools to support primary care practitioners. Internal Medicine Journal, 45(12), 1254-1266. WoS1 |
| 2015 | McCombie, A., Gearry, R., Andrews, J., Mikocka-Walus, A., & Mulder, R. (2015). Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review. Journal of Clinical Psychology in Medical Settings, 22(1), 20-44. Scopus33 WoS33 Europe PMC25 |
| 2015 | Reeve, E., Andrews, J., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2015). Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Annals of Pharmacotherapy, 49(1), 29-38. Scopus76 WoS58 Europe PMC54 |
| 2015 | De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Krejany, E., Gorelik, A., . . . Desmond, P. (2015). Crohn's disease management after intestinal resection: a randomised trial. The Lancet, 385(9976), 1406-1417. Scopus539 WoS482 Europe PMC397 |
| 2015 | Keeton, R., Mikocka-Walus, A., & Andrews, J. (2015). Concerns and worries in people living with inflammatory bowel disease (IBD): a mixed methods study. Journal of Psychosomatic Research, 78(6), 573-578. Scopus64 WoS57 Europe PMC49 |
| 2015 | Roberts, R. L., Wallace, M. C., Seinen, M. L., Krishnaprasad, K., Chew, A., Lawrance, I., . . . Barclay, M. L. (2015). Erratum: PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease (American Journal of Gastroenterology (2014) 109 (926) DOI: 10.1038/ajg.2014.89). American Journal of Gastroenterology, 110(1), 204. |
| 2015 | Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Ritchie, K., Krejany, E., . . . Gearry, R. (2015). Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. Gastroenterology, 148(5), 938-947.e1. Scopus264 WoS229 Europe PMC194 |
| 2015 | Williamson, K., Steveling, K., Holtmann, G., Schoeman, M., & Andrews, J. (2015). Clinical triage for colonoscopy is useful in young women. Internal Medicine Journal, 45(5), 492-496. Scopus7 WoS8 Europe PMC3 |
| 2015 | Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906. Scopus128 WoS116 Europe PMC106 |
| 2015 | Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Ritchie, K., Krejany, E., . . . Desmond, P. (2015). Effect of intestinal resection on quality of life in Crohn's disease. Journal of Crohn's and Colitis, 9(6), 452-462. Scopus30 WoS27 Europe PMC24 |
| 2015 | Mountifield, R., Andrews, J., Mikocka-Walus, A., & Bampton, P. (2015). Doctor communication quality and friends' attitudes influence complementary medicine use in inflammatory bowel disease. World Journal of Gastroenterology, 21(12), 3663-3670. Scopus42 WoS38 Europe PMC36 |
| 2015 | Bennett, A., Munkholm, P., & Andrews, J. (2015). Tools for primary care management of inflammatory bowel disease: do they exist?. World Journal of Gastroenterology, 21(15), 4457-4465. Scopus28 WoS25 Europe PMC25 |
| 2015 | Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2015). Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterology, 15(1), 54-1-54-12. Scopus70 WoS64 Europe PMC53 |
| 2015 | Stephens, M., Hourigan, L., Appleyard, M., Ostapowicz, G., Schoeman, M., Desmond, P., . . . Holtmann, G. (2015). Non-physician endoscopists: a systematic review. World Journal of Gastroenterology, 21(16), 5056-5071. Scopus17 WoS14 Europe PMC13 |
| 2015 | Costello, S. P., Chung, A., Andrews, J. M., & Fraser, R. J. (2015). Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. American Journal of Gastroenterology, 110(5), 775-777. Scopus23 WoS23 Europe PMC17 |
| 2015 | Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305. Scopus1 WoS1 Europe PMC1 |
| 2015 | Costello, S., Ghaly, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients. Internal Medicine Journal, 45(6), 659-666. Scopus4 WoS3 Europe PMC3 |
| 2015 | Goyette, P., Boucher, G., Mallon, D., Ellinghaus, E., Jostins, L., Huang, H., . . . Lee, J. C. (2015). High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nature Genetics, 47(2), 172-179. Scopus271 Europe PMC254 |
| 2015 | Williamson, K. D., Schoeman, M., & Andrews, J. M. (2015). Author reply. Internal Medicine Journal, 45(11), 1199. |
| 2015 | Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328. Scopus1 WoS1 Europe PMC1 |
| 2015 | Stewart, B., Turnbull, D., Mikocka-Walus, A., Harley, H., & Andrews, J. (2015). An aggravated trajectory of depression and anxiety co-morbid with hepatitis C: a within-groups study of 61 Australian outpatients. Clinical Practice and Epidemiology in Mental Health, 11(1), 174-179. Scopus3 Europe PMC1 |
| 2015 | Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Internal Medicine Journal, 45(2), 170-177. Scopus7 WoS7 Europe PMC7 |
| 2015 | McCallum, S., Mikocka-Walus, A., Turnbull, D., & Andrews, J. (2015). Continuity of care in dual diagnosis treatment: definitions, applications, and implications. Journal of Dual Diagnosis, 11(3-4), 217-232. Scopus21 WoS20 Europe PMC10 |
| 2015 | Kashkooli, S., Andrews, J., Roberts, M., Selinger, C., & Leong, R. (2015). Inflammatory bowel disease-specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians. United European Gastroenterology Journal, 3(5), 462-470. Scopus31 WoS26 Europe PMC20 |
| 2015 | Andrews, J. M. (2015). Editorial: Functional gastrointestinal disorders and body mass index. Alimentary Pharmacology and Therapeutics, 41(11), 1211-1212. |
| 2015 | Lunney, P., Kariyawasam, V., Wang, R., Middleton, K., Huang, T., Selinger, C., . . . Leong, R. (2015). Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Alimentary Pharmacology and Therapeutics, 42(1), 61-70. Scopus89 Europe PMC67 |
| 2015 | Bennett, A., Wichmann, M., Chin, J., Andrews, J., & Bampton, P. (2015). Rural inflammatory bowel disease care in Australia: disease outcomes and perceived barriers to optimal care. Health systems and policy research, 2(2), 1-10. |
| 2014 | Crocker, K., Chur-Hansen, A., & Andrews, J. (2014). Irritable bowel syndrome : Reply. Australian Family Physician, 43(1-2), 9. |
| 2014 | Kariyawasam, V. C., Selinger, C. P., Katelaris, P. H., Jones, D. B., McDonald, C., Barr, G., . . . Leong, R. W. (2014). Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Inflammatory Bowel Diseases, 20(8), 1382-1390. Scopus49 Europe PMC41 |
| 2014 | Pan, W. J., Köck, K., Rees, W. A., Sullivan, B. A., Evangelista, C. M., Yen, M., . . . Borie, D. C. (2014). Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases. British Journal of Clinical Pharmacology, 78(6), 1315-1333. Scopus29 Europe PMC27 |
| 2014 | Andrews, J., & Costello, S. (2014). The emerging role of faecal microbiota transplantation. Medicine Today, 15(7), 62-64. Scopus1 |
| 2014 | Ooi, S. Y. J., & Andrews, J. M. (2014). Ulcerative colitis: Unravelling the uncertainty in diagnosis and management. Medicine Today, 15(9), 36-44. |
| 2014 | Costello, S., La Brooy, J., Tucker, E., Holloway, R., Schoeman, M., & Andrews, J. M. (2014). Establishment of a fecal microbiota transplant service for the treatment of recurrent <i>Clostridium difficile</i> colitis in the Australian public hospital setting. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, 134. |
| 2014 | Stewart, B., Sindicich, N., Turnbull, D., Andrews, J., & Mikocka-Walus, A. (2014). Changes in Australian injecting drug users’ mental health problems and service uptake from 2006-2012. Advances in Dual Diagnosis, 7(4), 151-161. |
| 2014 | Julsgaard, M., Christensen, L. A., Fallingborg, J., Gearry, R., Radford-Smith, G., Walsh, A., . . . Bell, S. J. (2014). Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth. JOURNAL OF CROHNS & COLITIS, 8, S34-S35. WoS1 |
| 2014 | Wright, E., Williams, J., Andrews, J., Day, A., Gearry, R., Bampton, P., . . . De Cruz, P. (2014). Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Internal Medicine Journal, 44(5), 490-496. Scopus53 WoS49 Europe PMC47 |
| 2014 | Heap, G., Weedon, M., Bewshea, C., Singh, A., Chen, M., Satchwell, J., . . . Ahmad, T. (2014). HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), 1131-1134. Scopus175 WoS163 Europe PMC138 |
| 2014 | Hughes, P., Moretta, M., Lim, A., Grasby, D., Bird, D., Brierley, S., . . . Krumbiegel, D. (2014). Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients. Brain, Behavior, and Immunity, 42, 191-203. Scopus48 WoS44 Europe PMC40 |
| 2014 | Martindale, F., Mikocka-Walus, A., Walus, B., Keage, H., & Andrews, J. (2014). The effects of a designer music intervention on patients' anxiety, pain, and experience of colonoscopy: a short report on a pilot study. Gastroenterology Nursing, 37(5), 338-342. Scopus21 WoS22 Europe PMC17 |
| 2014 | Rollbusch, N., Mikocka-Walus, A., & Andrews, J. (2014). The experience of anxiety in colonoscopy outpatients: a mixed-method study. Gastroenterology Nursing, 37(2), 166-175. Scopus19 WoS15 Europe PMC13 |
| 2014 | Mountifield, R., Andrews, J., Mikocka-Walus, A., & Bampton, P. (2014). Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 8(12), 1723-1729. Scopus21 WoS21 Europe PMC13 |
| 2014 | Mikocka-Walus, A., Andrews, J., Rampton, D., Goodhand, J., van der Woude, J., & Bernstein, C. (2014). How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. Journal of Crohn's and Colitis, 8(12), 1668-1674. Scopus52 WoS46 Europe PMC45 |
| 2014 | Roberts, R. L., Wallace, M. C., Seinen, M. L., Krishnaprasad, K., Chew, A., Lawrance, I., . . . Barclay, M. L. (2014). PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease. American Journal of Gastroenterology, 109(6), 925-927. Scopus8 WoS7 Europe PMC6 |
| 2014 | Ooi, S. Y. J., & Andrews, J. M. (2014). Commentary: the association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease. Alimentary Pharmacology and Therapeutics, 39(11), 1331-1332. Scopus1 WoS1 Europe PMC1 |
| 2014 | Mountifield, R., Andrews, J., & Bampton, P. (2014). It IS worth the effort: patient knowledge of reproductive aspects of inflammatory bowel disease improves dramatically after a single group education session. Journal of Crohn's and Colitis, 8(8), 796-801. Scopus53 WoS46 Europe PMC35 |
| 2014 | Mountifield, R., Bampton, P., Prosser, R., Mikocka-Walus, A., & Andrews, J. (2014). Colon cancer surveillance in inflammatory bowel disease: unclear gain but no psychological pain?. Internal Medicine Journal, 44(2), 131-138. Scopus8 WoS6 Europe PMC4 |
| 2014 | Selinger, C., Andrews, J., Titman, A., Norton, I., Jones, D., McDonald, C., . . . Leong, R. (2014). Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 12(4), 644-650. Scopus85 WoS79 Europe PMC63 |
| 2014 | Mikocka-Walus, A., & Andrews, J. (2014). Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey. Journal of Crohn's and Colitis, 8(4), 296-303. Scopus17 WoS18 Europe PMC15 |
| 2014 | Gibson, P., Vaizey, C., Black, C., Nicholls, R., Weston, A., Bampton, P., . . . Fan, T. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. Journal of Crohn's and Colitis, 8(7), 598-606. Scopus99 WoS99 Europe PMC85 |
| 2013 | Lawrance, I., Murray, K., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., . . . Hanigan, K. (2013). Crohn's disease and smoking: is it ever too late to quit?. Journal of Crohn's and Colitis, 7(12), e665-e671. Scopus43 Europe PMC36 |
| 2013 | Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225. Scopus154 WoS146 Europe PMC124 |
| 2013 | Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176. Scopus5 WoS4 Europe PMC4 |
| 2013 | Stewart, B., Turnbull, D., Mikocka-Walus, A., Harley, H., & Andrews, J. (2013). Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C. Journal of Clinical Psychology in Medical Settings, 20(4), 427-439. Scopus4 WoS1 Europe PMC1 |
| 2013 | Crocker, K., Chur-Hansen, A., & Andrews, J. (2013). Interpersonal relationships for patients with irritable bowel syndrome: A qualitative study of gps' perceptions. Australian Family Physician, 42(11), 805-810. Scopus5 WoS3 Europe PMC3 |
| 2013 | McCallum, S., Mikocka-Walus, A., Keage, H., Churches, O., & Andrews, J. (2013). A novel treatment resource for co-occurring symptoms. Advances in Dual Diagnosis: policy, practice and research in mental health and substance use, 6(4), 155-167. Scopus1 WoS1 |
| 2013 | Selinger, C., Andrews, J., Dent, O., Norton, I., Jones, B., McDonald, C., . . . Leong, R. (2013). Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases, 19(9), 1880-1888. Scopus45 WoS49 Europe PMC40 |
| 2013 | Hughes, P., Harrington, A., Castro Kraftchenko, J., Liebregts, T., Adam, B., Grasby, D., . . . Brierley, S. (2013). Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut, 62(10), 1456-1465. Scopus183 WoS166 Europe PMC149 |
| 2013 | Andrews, J. (2013). Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Alimentary Pharmacology & Therapeutics, 38(6), 563-572. Scopus71 WoS62 Europe PMC56 |
| 2013 | Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2013). 'Just to get it off my chest': patients' views on psychotherapy in inflammatory bowel disease. Counselling and Psychotherapy Research; linking research with practice, 13(3), 227-234. Scopus6 WoS4 |
| 2013 | Ahl, A., Mikocka-Walus, A., Gordon, A., & Andrews, J. (2013). Are self-administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): A systematic review. Journal of Psychosomatic Research, 75(2), 113-120. Scopus18 WoS16 Europe PMC16 |
| 2013 | Lim, A., Grafton, R., Hetzel, D., & Andrews, J. (2013). Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines - is there a problem?. Internal Medicine Journal, 43(7), 803-809. Scopus4 WoS3 Europe PMC3 |
| 2013 | Hughes, P., Zola, H., Penttila, I., Blackshaw, L., Andrews, J., & Krumbiegel, D. (2013). Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?. American Journal of Gastroenterology, 108(7), 1066-1074. Scopus135 WoS116 Europe PMC109 |
| 2013 | Kennedy, N., Asser, T., Mountifield, R., Doogue, M., Andrews, J., & Bampton, P. (2013). Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Internal Medicine Journal, 43(3), 278-286. Scopus24 WoS25 Europe PMC21 |
| 2013 | Zschau, N., Andrews, J., Holloway, R., Schoeman, M., Lange, K., Tam, W., & Holtmann, G. (2013). Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting. World Journal of Gastroenterology, 19(16), 2514-2520. Scopus6 WoS6 Europe PMC5 |
| 2013 | Mikocka-Walus, A., Andrews, J., von Kanel, R., & Moser, G. (2013). What are the implications of changing treatment delivery models for patients with inflammatory bowel disease: a discussion paper. European Journal of Gastroenterology & Hepatology, 25(4), 393-398. Scopus17 WoS16 Europe PMC11 |
| 2013 | Doecke, J., Simms, L., Zhao, Z., Huang, N., Hanigan, K., Krishnaprasad, K., . . . Radford-Smith, G. (2013). Genetic susceptibility in IBD: Overlap between ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases, 19(2), 240-245. Scopus38 WoS36 Europe PMC34 |
| 2013 | Selinger, C. P., Leong, R. W. L., & Andrews, J. M. (2013). Cancer surveillance for patients with colonic Crohn's disease: Will your patients benefit?. Journal of Crohn S and Colitis, 7(12), e714. |
| 2013 | Andrews, J. M. (2013). Commentary: IBD combination therapy - Adalimumab plus immunosuppressants. Alimentary Pharmacology and Therapeutics, 37(1), 156. |
| 2013 | Fazal, M. W., Doogue, M. P., Leong, R. W., Bampton, P. A., & Andrews, J. M. (2013). Allopurinol use in pregnancy in three women with inflammatory bowel disease: Safety and outcomes: A case series. BMC Gastroenterology, 13(1), 5 pages. Scopus12 WoS11 Europe PMC10 |
| 2013 | Andrews, J. M. (2013). Commentary: Predicting relapse in Crohn's disease patients in remission with biologics. Alimentary Pharmacology and Therapeutics, 37(4), 497-498. Scopus2 Europe PMC2 |
| 2012 | Phan, V. -A. H., van Langenberg, D. R., Grafton, R., & Andrews, J. M. (2012). A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre. FRONTLINE GASTROENTEROLOGY, 3(3), 137-142. WoS20 Europe PMC14 |
| 2012 | Mikocka-Walus, A., Moulds, L., Rollbusch, N., & Andrews, J. (2012). "It's a tube up your bottom; it makes people nervous": the experience of anxiety in initial colonoscopy patients. Gastroenterology Nursing, 35(6), 392-401. Scopus30 WoS27 Europe PMC20 |
| 2012 | Stewart, B., Mikocka-Walus, A., Morgan, J., Colman, A., Phelps, M., Harley, H., & Andrews, J. (2012). Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors. Australasian Psychiatry, 20(6), 496-500. Scopus16 WoS14 Europe PMC15 |
| 2012 | Jostins, L., & Andrews, J. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491(7422), 119-124. Scopus3953 WoS3702 Europe PMC3590 |
| 2012 | Mikocka-Walus, A., Andrews, J., Bernstein, C., Graff, L., Walker, J., Spinelli, A., . . . Moser, G. (2012). Integrated models of care in managing inflammatory bowel disease: a discussion. Inflammatory Bowel Diseases, 18(8), 1582-1587. Scopus64 WoS59 Europe PMC51 |
| 2012 | Van Langenberg, D., & Andrews, J. (2012). Satisfaction with patient-doctor relationships in inflammatory bowel diseases: examining patient-initiated change of specialist. World Journal of Gastroenterology, 18(18), 2212-2218. Scopus17 WoS12 Europe PMC13 |
| 2012 | Gapasin, J., Van Langenberg, D., Holtmann, G., Hetzel, D., & Andrews, J. (2012). Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit. Internal Medicine Journal, 42(5), e84-e88. Scopus5 WoS5 Europe PMC5 |
| 2012 | Tan, M., Holloway, R., Lange, K., & Andrews, J. (2012). General Practitioners' Knowledge of, and Attitudes to, Inflammatory Bowel Disease (IBD). Internal Medicine Journal (online), 42(7), 801-807. Scopus43 WoS40 Europe PMC38 |
| 2012 | Stewart, B., Mikocka-Walus, A., Harley, H., & Andrews, J. (2012). Help-seeking and coping with the psychosocial burden of chronic Hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives. International Journal of Nursing Studies, 49(5), 560-569. Scopus41 WoS38 Europe PMC40 |
| 2012 | Mikocka-Walus, A., Turnbull, D., Holtmann, G., & Andrews, J. (2012). An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation. Inflammatory Bowel Diseases, 18(8), 1573-1581. Scopus39 WoS38 Europe PMC31 |
| 2012 | Krishnaprasad, K., Andrews, J., Lawrance, I., Florin, T., Gearry, R., Leong, R., . . . Radford-Smith, G. (2012). Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study. Journal of Crohn's and Colitis, 6(3), 287-293. Scopus15 WoS13 Europe PMC11 |
| 2012 | Holtmann, G., & Andrews, J. (2012). A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. Journal of Crohn's and Colitis, 6(3), 302-310. Scopus96 WoS93 Europe PMC86 |
| 2012 | Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2012). The role of antidepressants in the management of inflammatory bowel disease (IBD): A short report on a clinical case-note audit. Journal of Psychosomatic Research, 72(2), 165-167. Scopus35 WoS35 Europe PMC28 |
| 2012 | Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2012). A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterology, 12(93), 1-9. Scopus28 WoS21 Europe PMC19 |
| 2012 | Andrews, J. M., & Tan, M. (2012). Probiotics in luminal gastroenterology: the current state of play. Internal Medicine Journal, 42(12), 1287-1291. Scopus24 WoS18 Europe PMC13 |
| 2012 | Mikocka-Walus, A., Moulds, L., Rollbusch, N., & Andrews, J. (2012). Why do colonoscopy patients reject research?. Journal of Psychosomatic Research, 72(4), 249-250. Scopus1 WoS1 Europe PMC1 |
| 2011 | Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923. Scopus77 WoS71 Europe PMC63 |
| 2011 | Besanko, L., Burgstad, C., Mountifield, R., Andrews, J., Heddle, R., Checklin, H., & Fraser, R. (2011). Lower esophageal sphincter relaxation is impaired in older patients with dysphagia. World Journal of Gastroenterology, 17(10), 1326-1331. Scopus25 WoS22 Europe PMC17 |
| 2011 | Andrews, J. (2011). Le plus ca change: Why we need better biomarkers to predict outcomes in ulcerative colitis. Journal of Gastroenterology and Hepatology, 26(7), 1085-1086. Scopus3 WoS1 |
| 2011 | Haag, S., Andrews, J., Gapasin, J., Gerken, G., Keller, A., & Holtmann, G. (2011). A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors. Alimentary Pharmacology & Therapeutics, 33(6), 722-729. Scopus33 WoS29 Europe PMC20 |
| 2011 | Andrews, J., & Holtmann, G. (2011). Stress causes flares of IBD: how much evidence is enough?. Nature Reviews Gastroenterology and Hepatology, 8(1), 13-14. Scopus12 WoS11 Europe PMC11 |
| 2010 | Mountifield, R., Prosser, R., Bampton, P., Muller, K., & Andrews, J. (2010). Pregnancy and IBD treatment: This challenging interplay from a patients' perspective. Journal of Crohn's and Colitis, 4(2), 176-182. Scopus77 WoS71 Europe PMC63 |
| 2010 | Andrews, J., Mountifield, R., Van Langenberg, D., Bampton, P., & Holtmann, G. (2010). Un-promoted Issues in Inflammatory Bowel Disease (IBD): Opportunities to Optimise Care. Internal Medicine Journal, 40(3), 173-182. Scopus46 WoS41 Europe PMC36 |
| 2010 | Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703. Scopus3 WoS2 |
| 2010 | Lawrance, I., Radford-Smith, G., Bampton, P., Andrews, J., Tan, P., Croft, A., . . . Florin, T. (2010). Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience. Journal of Gastroenterology and Hepatology, 25(11), 1732-1738. Scopus80 WoS70 Europe PMC63 |
| 2010 | Van Langenberg, D., Lange, K., Hetzel, D., Holtmann, G., & Andrews, J. (2010). Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change. Journal of Gastroenterology and Hepatology, 25(7), 1250-1258. Scopus33 WoS31 Europe PMC31 |
| 2010 | Muller, K., Prosser, R., Bampton, P., Mountifield, R., & Andrews, J. (2010). Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflammatory Bowel Diseases, 16(4), 657-663. Scopus169 WoS151 Europe PMC137 |
| 2010 | Connell, W., Andrews, J., & Sparrow, M. (2010). Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia. Internal Medicine Journal, 40(2), 139-149. Scopus14 WoS11 Europe PMC7 |
| 2010 | Van Langenberg, D., Simon, S., Holtmann, G., & Andrews, J. (2010). The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: A single metropolitan Australian center experience. Journal of Crohn's and Colitis, 4(4), 413-421. Scopus29 WoS29 Europe PMC28 |
| 2010 | Mountifield, R., & Andrews, J. M. (2010). Managing irritable bowel syndrome. Medicine Today, 11(2), 32-40. Scopus2 |
| 2010 | Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). A necessary evil: patients' experiences of and attitudes to surgical care for Inflammatory Bowel Disease (IBD). JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, A87. |
| 2010 | Kennedy, N. A., Doogue, M., Andrews, J. M., & Bampton, P. A. (2010). How thiopurine metabolite measurements affect management of inflammatory bowel disease, South Australia: the first 18 months. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, A99. |
| 2009 | Haag, S., Andrews, J., Gapasin, J., Keller, A., & Holtmann, G. (2009). Eine 13-Länderstudie zu Oberbauchbeschwerden: Die Bedeutung von Alter und Geschlecht. Zeitschrift für Gastroenterologie, 47(09). |
| 2009 | Haag, S., Andrews, J., Katelaris, P., Gapasin, J., Galmiche, J., Hunt, R., . . . Holtmann, G. (2009). Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines. Digestion, 80(4), 226-234. Scopus33 WoS24 Europe PMC18 |
| 2009 | Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., & Holtmann, G. (2009). Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial. European Journal of Gastroenterology & Hepatology, 21(4), 394-395. Scopus4 WoS1 Europe PMC5 |
| 2009 | Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., & Holtmann, G. (2009). Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Internal Medicine Journal, 39(2), 127-130. Scopus16 WoS15 Europe PMC12 |
| 2009 | Andrews, J., Travis, S., Gibson, P., & Gasche, C. (2009). Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?. Alimentary Pharmacology & Therapeutics, 29(5), 459-469. Scopus56 WoS49 Europe PMC40 |
| 2009 | Mountifield, R., Bampton, P., Prosser, R., Muller, K., & Andrews, J. (2009). Fear and fertility in inflammatory bowel disease; A mismatch of perception and reality affects family planning decisions. Inflammatory Bowel Diseases, 15(5), 720-725. Scopus222 WoS194 Europe PMC166 |
| 2009 | Collins, J., Farrall, E., Turnbull, D., Hetzel, D., Holtmann, G., & Andrews, J. (2009). Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. Clinical Gastroenterology and Hepatology, 7(11), 1252-1254. Scopus37 WoS34 Europe PMC31 |
| 2009 | Andrews, J., Heddle, R., Hebbard, G., Checklin, H., Besanko, L., & Fraser, R. (2009). Age and gender affect likely manometric diagnosis: Audit of a tertiary referral hospital clinical esophageal manometry service. Journal of Gastroenterology and Hepatology, 24(1), 125-128. Scopus23 WoS16 Europe PMC16 |
| 2009 | Van Langenberg, D. R., & Andrews, J. M. (2009). Do IBD patients change specialists? if so, does it matter?. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, A225-A226. |
| 2008 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2008). Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. Journal of Gastroenterology and Hepatology, 23(7 Part 1), 1137-1143. Scopus40 WoS39 Europe PMC34 |
| 2008 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Holtmann, G., & Andrews, J. (2008). Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: An observational cohort prospective study. BioPsychoSocial Medicine, 2(11), 1-9. Scopus52 WoS46 Europe PMC40 |
| 2008 | Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., Harley, H., . . . Holtmann, G. (2008). Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clinical Practice and Epidemiology in Mental Health, 4(article no. 15), 1-8. Scopus60 Europe PMC40 |
| 2008 | Andrews, J., Fraser, R., Heddle, R., Hebbard, G., & Checklin, H. (2008). Is esophageal dysphagia in the extreme elderly (≥80 years) different to dysphagia younger adults? A clinical motility service audit. Diseases of the Esophagus, 21(7), 656-659. Scopus18 WoS16 Europe PMC11 |
| 2008 | Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., & Holtmann, G. (2008). The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 28(4), 475-483. Scopus56 WoS56 Europe PMC44 |
| 2007 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2007). "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterology, 7(1), 38-43. Scopus41 WoS36 Europe PMC33 |
| 2007 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2007). Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review. Inflammatory Bowel Diseases, 13(2), 225-234. Scopus155 WoS137 Europe PMC119 |
| 2006 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2006). Antidepressants and inflammatory bowel disease: a systematic review. Clinical Practice and Epidemiology in Mental Health, 2(24), 1-9. Scopus113 Europe PMC90 |
| 2006 | Andrews, J. M. (2006). Letter: "Positive" family planning: Another personal viewpoint. Medical Journal of Australia, 184(12), 645-646. |
| 2006 | Andrews, J. M. (2006). "Positive" family planning: Another personal viewpoint [3]. Medical Journal of Australia, 184(12), 645-646. |
| 2003 | Andrews, J. M. (2003). Letter to the editor [2]. Neurogastroenterology and Motility, 15(3), 335. |
| 2003 | Feinle-Bisset, C., O'Donovan, D., Doran, S., Andrews, J., Wishart, J., Chapman, I., & Horowitz, M. (2003). Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. American Journal of Physiology-Gastrointestinal and Liver Physiology, 284(5), G798-G807. Scopus172 WoS161 Europe PMC134 |
| 2003 | Feinle-Bisset, C., & Andrews, J. (2003). Treatment of functional dyspepsia. Current Treatment Options in Gastroenterology, 6(4), 289-297. Europe PMC7 |
| 2002 | Andrews, J., O'Donovan, D., Hebbard, G., Malbert, C., Doran, S., & Dent, J. (2002). Human duodenal phase III migrating motor complex activity is predominantly antegrade, as revealed by high-resolution manometry and colour pressure plots. Neurogastroenterology and Motility, 14(4), 331-338. Scopus25 WoS19 Europe PMC15 |
| 2002 | Andrews, J. (2002). Hiatus hernia: What the GP needs to know. Medicine Today, 3(1), 39-43. |
| 2001 | Andrews, J., Doran, S., Di Matteo, A., Leong, L., MacIntosh, C., Chiu, C., . . . Fraser, R. (2001). Effect of a lacto-ovo vegetarian diet on fasting small intestinal motility. Scandinavian Journal of Gastroenterology, 36(10), 1037-1043. Scopus2 WoS1 Europe PMC1 |
| 2001 | Andrews, J., Doran, S., Hebbard, G., Malbert, C., Horowitz, M., & Dent, J. (2001). Nutrient-induced spatial patterning of human duodenal motor function. American Journal of Physiology-Gastrointestinal and Liver Physiology, 280(3), G501-G509. Scopus44 WoS34 Europe PMC21 |
| 1999 | Andrews, J., Nathan, H., Malbert, C. H., Verhagen, M., Gabb, M., Hebbard, G., . . . Dent, J. (1999). Validation of a novel luminal flow velocimeter with video fluoroscopy and manometry in the human esophagus. The American journal of physiology, 276(4), G886-G894. Scopus1 WoS1 |
| 1999 | Verhagen, M. A. M. T., Rayner, C. K., Andrews, J. M., Hebbard, G. S., Doran, S. M., Samsom, M., & Horowitz, M. (1999). Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects. American Journal of Physiology Gastrointestinal and Liver Physiology, 276(3 39-3), G761-G766. Scopus29 WoS26 Europe PMC12 |
| 1999 | MacIntosh, C., Andrews, J., Jones, K., Wishart, J., Morris, H., Jansen, J., . . . Chapman, I. (1999). Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. American Journal of Clinical Nutrition, 69(5), 999-1006. Scopus219 WoS199 Europe PMC161 |
| 1998 | Andrews, J. M., Doran, S., Hebbard, G. S., Rassias, G., Sun, W. M., & Horowitz, M. (1998). Effect of glucose supplementation on appetite and the pyloric motor response to intraduodenal glucose and lipid. American Journal of Physiology Gastrointestinal and Liver Physiology, 274(4 37-4), G645-G652. Scopus30 WoS27 Europe PMC17 |
| 1998 | Andrews, J., Rayner, C., Doran, S., Hebbard, G., & Horowitz, M. (1998). Physiological changes in blood glucose affect appetite and pyloric motility during intraduodenal lipid infusion. American Journal of Physiology. Gastrointestinal and Liver Physiology, 275(4), G797-G804. Scopus41 WoS39 Europe PMC19 |
| 1998 | Doran, S., Jones, K., Andrews, J., & Horowitz, M. (1998). Effects of meal volume and posture on gastric emptying of solids and appetite. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 275(5), R1712-R1718. Scopus78 WoS67 Europe PMC51 |
| 1998 | Andrews, J., Doran, S., Hebbard, G., Rassias, G., Sun, W. M., & Horowitz, M. (1998). The effect of dietary supplementation with glucose on appetite and antropyloroduodenal motility. American Journal of Physiology, 274, G645-G652. |
| 1998 | Lavin, J., Wittert, G., Andrews, J., Yeap, B., Wishart, J., Morris, H., . . . Read, N. (1998). Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate1–3. American Journal of Clinical Nutrition, 68(3), 591-598. Scopus113 WoS96 Europe PMC73 |
| 1997 | Cook, C., Andrews, J., Jones, K., Wittert, G., Chapman, I., Morley, J., & Horowitz, M. (1997). The effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 273(2), R755-R761. WoS106 |
| 1997 | Smithson, J., Campbell, A., Andrews, J., Milton, J., Pigott, R., & Jewell, D. (1997). Altered expression of mucins throughout the colon in ulcerative colitis.. Gut, 40(2), 234-240. Scopus36 |
| 1997 | Russo, A., Sun, W. M., Sattawatthamrong, Y., Fraser, R., Horowitz, M., Boeckxstaens, G., . . . Read, N. (1997). Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects. Gut, 41(4), 494-499. Scopus45 WoS39 Europe PMC24 |
| 1997 | Hebbard, G., Samsom, M., Andrews, J., Carman, D., Tansell, B., Sun, W. M., . . . Horowitz, M. (1997). Hyperglycaemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion.. Digestive Diseases and Sciences, 42(3), 568-575. Scopus35 WoS29 Europe PMC22 |
| 1996 | Andrews, J., & Horowitz, M. (1996). Gastric function in the elderly. Clinical Geriatrics, 4, 21-43. |
| 1995 | Andrews, J., Norton, I., Dent, O., & Goulston, K. (1995). Inflammatory bowel disease: A retrospective review of a specialist based cohort. Medical Journal of Australia, 163(3), 133-136. Scopus16 Europe PMC12 |
| 1994 | Andrews, J., & Goulston, K. (1994). Inflammatory bowel disease - Its history, current status and outlook. Medical Journal of Australia, 160(4), 219-223. Scopus10 Europe PMC5 |
| 1993 | Andrews, J. (1993). Gastric mucosal phospholipids and gastroduodenal diseases. Gut, 34(12), 1741-1742. |
| 1990 | Rush, D., Andrews, J., Kristal, A., Kristal, A., & Andrews, J. (1990). Maternal Cigarette Smoking During Pregnancy, Adiposity, Social Class, and Perinatal Outcome in Cardiff, Wales, 1965-1977. American Journal of Perinatology, 7(4), 319-326. Scopus9 Europe PMC5 |
| 1983 | Jones, B. J. M., Lees, R., Andrews, J., Frost, P., & Silk, D. B. (1983). Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut, 24(1), 78-84. Scopus109 Europe PMC87 |
| Year | Citation |
|---|---|
| 2019 | Duong, T., & Andrews, J. M. (2019). Common gastrointestinal investigations and psychological concerns. In Psychogastroenterology for Adults A Handbook for Mental Health Professionals (pp. 105-118). Routledge. DOI |
| 2018 | Linedale, E., Mikocka-Walus, A., & Andrews, J. (2018). Future challenges and directions in functional gastrointestinal disorders - integrated biopsychosocial care approaches. In S. Knowles, J. Stern, & G. Hebbard (Eds.), Functional Gastrointestinal Disorders. A Biopsychosocial Approach (pp. 288-296). New York, NY: Routledge. |
| 2015 | Andrews, J. (2015). IBD: What is it and does psyche have anything to do with it?. In S. Knowles, & A. Mikocka-Walus (Eds.), Psychological Aspects of Inflammatory Bowel Disease: A Biopsychosocial Approach (pp. 1-9). Hove, East Sussex: Routledge. DOI Scopus1 |
| 2010 | Blackshaw, L., & Andrews, J. (2010). Small intestinal motor and sensory function and dysfunction. In Sleisenger and Fortran's Gastrointestinal and Liver Disease: Pathology, Diagnosis, Management (9 ed., pp. 1643-1659). United States: Elsevier Saunders. Scopus2 |
| 2006 | Mikocka-Walus, A., Turnbull, D., Moulding, N., Andrews, J., & Holtmann, G. (2006). Do antidepressants have an impact on the course of inflammatory bowel disease: South Australian gatroenterologists' perspectives. In D. M. Katsikitis (Ed.), Unknown Book (pp. 259-263). Level 11, 257 Collins Street, Melbourne VIC: AUSTPSYCHSOC. |
| Year | Citation |
|---|---|
| 2024 | Goodsall, T. M., Day, A. S., Andrews, J. M., Ruszkiewicz, A., Ma, C., & Bryant, R. V. (2024). Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study. In Inflammatory Bowel Diseases Vol. 30 (pp. 190-195). England: OXFORD UNIV PRESS INC. DOI Scopus20 WoS23 Europe PMC16 |
| 2024 | Bills, E. R., Westin, A. D., & Andrews, J. M. (2024). IMPLEMENTING THE ‘MY PREHAB PROGRAM’: HOW DIGITAL TECHNOLOGY HELPED TO BRIDGE THE HOSPITAL-COMMUNITY GAP AND STREAMLINE HOSPITAL PROCESSES. In Asia Pacific Journal of Health Management Vol. 19. Australasian College of Health Service Management. DOI |
| 2022 | Andrews, J. M., D'Haens, G., Kobayashi, T., Morris, N., Lissoos, T., Hoover, A., . . . Sands, B. E. (2022). Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 LUCENT-1 study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 132-133). WILEY. |
| 2022 | An, Y. -K., Lindsay, N., Allan, N., Khoo, E., Amiss, A., Moniruzzaman, M., . . . Begun, J. (2022). Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 146-147). WILEY. |
| 2022 | Lores, T., Andrews, J. M., Evans, S., Chur-Hansen, A., Goess, C., Smith, L., . . . Mikocka-Walus, A. (2022). A randomized controlled pilot trial of virtual adjunctive gut-directed hypnotherapy for people with Crohn's disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 130-131). WILEY. WoS1 |
| 2022 | Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. G. (2022). Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the Phase 2 GALAXI-1 study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 127-129). WILEY. |
| 2022 | Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. (2022). Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study. In JOURNAL OF CROHNS & COLITIS Vol. 16 (pp. I026-I027). OXFORD UNIV PRESS. WoS11 |
| 2022 | Barnes, A., Carter, D., Kaazan, P., Walsh, A., Connor, S., & Andrews, J. M. (2022). Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care. In Intestinal Research Vol. 20 (pp. 506-508). Korea (South): KOREAN ASSOC STUDY INTESTINAL DISEASES. DOI Scopus1 WoS1 Europe PMC1 |
| 2022 | Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. G. (2022). Clinical Efficacy and Safety of Guselkumab Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: Week 48 Analyses from the Phase 2 GALAXI 1 Study. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3656-3660). PA, Philadelphia: WILEY. |
| 2022 | Begun, J., Andrews, J., Chuang, E., Rahimian, P., Smith, J. A., & Singh, S. (2022). Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC). In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 117 (pp. S574). LIPPINCOTT WILLIAMS & WILKINS. |
| 2022 | Afzali, A., Panes, J., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Terry, N. (2022). Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn's Disease. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 117 (pp. S580). LIPPINCOTT WILLIAMS & WILKINS. |
| 2021 | Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., Mcivor, C., & Andrews, J. (2021). Weight and body mass index patterns in a cohort of patients with inflammatory bowel disease treated with biological agents. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 105-106). WILEY. |
| 2021 | Barnes, A., Spizzo, P., Mountifield, R., Bampton, P., Andrews, J., Fraser, R. J., & Mukherjee, S. (2021). Sleep quality in patients with inflammatory bowel disease: A systematic review and meta-analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 101). WILEY. |
| 2021 | Pipicella, J. L., Vernon-Roberts, A., Walsh, A., Wierzbicki, A., Day, A. S., Carter, D. W., . . . Andrews, J. M. (2021). Using a consensus-based method to develop a novel pediatric-specific inflammatory bowel disease eHealth clinical management system. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 165-166). WILEY. |
| 2021 | Duong, T. A., Bryant, R., Andrews, J., & Lynch, K. (2021). High reported willingness to have COVID-19 vaccination among Australian patients with inflammatory bowel disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 127). WILEY. |
| 2021 | Abeyratne, K., Harb, M., Bensted, K., Ghaly, S., Connor, S., Andrews, J., & Lynch, K. (2021). Validity of stomal calprotectin measurement in assessing Crohn's disease activity. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 125). WILEY. |
| 2021 | Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., McIvor, C., & Andrews, J. M. (2021). Weight patterns in biologicals treated Inflammatory bowel disease cohort. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S385-S386). OXFORD UNIV PRESS. DOI |
| 2021 | Day, A., Yao, C. K., Costello, S., Andrews, J., & Bryant, R. (2021). Food-related quality of life in adults with Inflammatory Bowel Disease is influenced by restrictive eating behaviour, disease activity and surgery: a prospective multi-centre study. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S368). OXFORD UNIV PRESS. DOI |
| 2021 | Danese, S., Sandborn, W. J., Feagan, B. G., Weisel, K., Gonzalez, S., Frustaci, M. E., . . . Panes, J. (2021). The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn's Disease: Results from the phase 2 GALAXI 1 study. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S027-S028). OXFORD UNIV PRESS. DOI WoS4 |
| 2020 | Day, A., Yao, C. K., Costello, S., Ruszkiewicz, A., Andrews, J., Gibson, P., & Bryant, R. (2020). Evaluation of the tolerance and effect on disease activity of a new dietary strategy (4-SURE diet) for mild-moderately active ulcerative colitis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 191-192). WILEY. WoS1 |
| 2020 | Barnes, A., Spizzo, P., Andrews, J., & Mountifield, R. (2020). Medication non-adherence among patients with inflammatory bowel disease during the COVID-19 pandemic is associated with increased disease activity and corticosteroid usage. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 135). WILEY. |
| 2020 | Tan, Z., Kaazan, P., Maiyani, P., Bednarz, J., Mcivor, C., & Andrews, J. M. (2020). Group-based trajectory analysis of weight change in an infliximab-treated cohort of patients with inflammatory bowel disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 127). WILEY. |
| 2019 | Kaazan, P., Krishnaprasad, K., Mountifield, R., & Andrews, J. (2019). Disease-specific electronic medical records in chronic disease: Is the emerging inflammatory bowel disease experience a possible solution?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 34 (pp. 127-128). WILEY. |
| 2019 | Kaazan, P., Tan, Z., Hughes, J., Grafton, R., & Andrews, J. (2019). Infliximab-related weight gain in patients with inflammatory bowel disease: Patterns, associations, and financial impacts. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 34 (pp. 138-139). WILEY. |
| 2019 | Lim, E., Thai, M., Hendy, P., Alchlaihawi, M., Leong, R., Connor, S., . . . Begun, J. (2019). Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S374). OXFORD UNIV PRESS. DOI |
| 2018 | Lores, T. J., Goess, C., Grafton, R., Hughes, J. C., Cronin, L., Burke, A., . . . Andrews, J. M. (2018). Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care. In GASTROENTEROLOGY Vol. 154 (pp. S806). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). P170 Integrated psychological care in outpatients with inflammatory bowel disease. In Journal of Crohn's and Colitis Vol. 11 (pp. S163). Oxford University Press (OUP). DOI |
| 2015 | Linedale, E. C., Mikocka-Walus, A., Gibson, P. G., & Andrews, J. M. (2015). Could a structured screening approach be the answer to the avalanche of functional gastrointestinal disorder referrals?. In Journal of Gastroenterology and Hepatology Vol. 30 (pp. 20). Brisbane, Queensland, Australia. |
| 2015 | Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study. In GASTROENTEROLOGY Vol. 148 (pp. S861). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. WoS1 |
| 2015 | Wright, E. K., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Hamilton, A. L., . . . Singh, S. (2015). Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels. In GASTROENTEROLOGY Vol. 148 (pp. S849). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2015 | Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications. In GASTROENTEROLOGY Vol. 148 (pp. S238-S239). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2015 | Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study. In GASTROENTEROLOGY Vol. 148 (pp. S116). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2014 | Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the POCER Study. In GASTROENTEROLOGY Vol. 146 (pp. S435). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2014 | Bennett, A., Moore, D., Bampton, P. A., & Andrews, J. M. (2014). What Happens to Patients With Paediatric Onset Inflammatory Bowel Disease (IBD) After Transition to Adult Care and What Is Their View of the Process?. In GASTROENTEROLOGY Vol. 146 (pp. S373-S374). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2014 | Bennett, A., Wichmann, M., Andrews, J. M., & Bampton, P. A. (2014). Rural and Remote Care for Patients With Inflammatory Bowel Disease - Perceived Barriers Despite Good Non-Expert Practitioner Knowledge. In GASTROENTEROLOGY Vol. 146 (pp. S373). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2014 | Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study. In GASTROENTEROLOGY Vol. 146 (pp. S174). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2014 | Heap, G. A., Singh, A., Bewshea, C. M., Weedon, M., Dubois, P., Andrews, J. M., . . . Ahmad, T. (2014). Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease: Clinical Features and Genetic Determinants. In GASTROENTEROLOGY Vol. 146 (pp. S2). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2013 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. In GASTROENTEROLOGY Vol. 144 (pp. S164). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC. WoS14 |
| 2013 | Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K., Krejany, S., . . . Desmond, P. V. (2013). Faecal calprotectin helps determine the need for post-operative colonoscopy in crohn's disease. prospective longitudinal endoscopic validation. Results from the POCER study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 28 (pp. 106). WILEY-BLACKWELL. WoS2 |
| 2013 | Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, A., Nguyen, N. Q., . . . Brierley, S. M. (2013). Alterations in the Guanylate Cyclase-C/cGMP Pathway in Patients With Irritable Bowel Syndrome With Constipation. In GASTROENTEROLOGY Vol. 144 (pp. S59-S60). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC. |
| 2013 | Mikocka-Walus, A., Andrews, J., von Kanel, R., & Moser, G. (2013). An improved model of care for inflammatory bowel disease (IBD). In Journal of Crohn's and Colitis Vol. 7 (pp. 120-121). UK: Elsevier BV. DOI Scopus7 Europe PMC6 |
| 2012 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study. In GASTROENTEROLOGY Vol. 142 (pp. S568). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. WoS5 |
| 2012 | Radford-Smith, G., Hartnell, F., Jones, L. V., Krishnaprasad, K., Prosser, R., Marr, D., . . . Gearry, R. B. (2012). Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease. In GASTROENTEROLOGY Vol. 142 (pp. S360). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. WoS1 |
| 2012 | Radford-Smith, G., Krishnaprasad, K., Andrews, J. M., Bampton, P. A., Simms, L., Mahy, G., . . . Lawrance, I. C. (2012). Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study. In GASTROENTEROLOGY Vol. 142 (pp. S262). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. |
| 2012 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study. In GASTROENTEROLOGY Vol. 142 (pp. S212). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. WoS16 |
| 2010 | Mikocka Walus, A., Holtmann, G., & Andrews, J. (2010). Psychogastroenterology: A biopsychosocial approach to treating inflammatory bowel disease. In Australian Society for Medical Research Annual Meeting 2010 Vol. 138 (pp. S161). Adelaide, Australia: Australian Society for Medical Research. |
| 2010 | Mikocka-Walus, A. A., Bond, M., Holloway, R. H., Persson, J., Pilichiewicz, A. N., Hughes, P. A., . . . Andrews, J. M. (2010). Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial. In GASTROENTEROLOGY Vol. 138 (pp. S521-S522). W B SAUNDERS CO-ELSEVIER INC. WoS6 |
| 2010 | Mikocka Walus, A., & Andrews, J. (2010). Establishing a biopsychosocial model of care for gastroenterology outpatients: A South Australia experience. In Psychosomatic Medicine in different medical settings - from basic care to specialization Vol. 68 (pp. 649). Adelaide, Australia: European Association for Consultation-Liaison Psychiatry & Psychosomatics. |
| 2009 | Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Florin, T. H. (2009). Serious Infective Complications in Anti-TNFα Treated Inflammatory Bowel Disease Patients. In GASTROENTEROLOGY Vol. 136 (pp. A189). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2009 | Zschau, N. B., Holtmann, G., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Andrews, J. M. (2009). Do Concomitant Functional Dyspepsia and Irritable Bowel Syndrome Influence Changes in Quality of Life in Patients with Gastroesophageal Reflux Symptoms Referred for Endoscopy? - the MAPSOMAL Study. In GASTROENTEROLOGY Vol. 136 (pp. A431). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. |
| 2008 | Muller, K. R., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). Female gender and surgery lead to greater perceived impact of inflammatory bowel disease (IBD) on body image and sexual function: a neglected issue. In GASTROENTEROLOGY Vol. 134 (pp. A140). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. WoS2 |
| 2008 | Mountifield, R. E., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). Fear and fertility in Inflammatory Bowel Disease - A mismatch of perception and reality affects patient behaviour. In GASTROENTEROLOGY Vol. 134 (pp. A641). W B SAUNDERS CO-ELSEVIER INC. |
| 2008 | Andrews, J. M., Mikocka-Walus, A. A., Turnbull, D. A., Hetzel, D. J., & Hohmann, G. J. (2008). Concomitant symptoms of functional gastrointestinal disorders (FGIDs) in patients with Inflammatory Bowel Disease (IBD) are associated with decreased quality of life (Qol). In GASTROENTEROLOGY Vol. 134 (pp. A499). W B SAUNDERS CO-ELSEVIER INC. |
| 2008 | Mikocka-Walus, A. A., Andrews, J. M., Turnbull, D. A., Wilson, I. G., & Holtmann, G. J. (2008). Psychological co-morbidity and quality of life (Qol) vary between inflammatory bowel disease (IBD) cohorts in different regions and amongst IBD and other chronic diseases in the one region. In GASTROENTEROLOGY Vol. 134 (pp. A499-A500). W B SAUNDERS CO-ELSEVIER INC. |
| 2006 | Mikocka Walus, A., Turnbull, D., Moulding, N. T., Andrews, J., & Holtmann, G. (2006). Do antidepressants have an impact on the course of inflammatory bowel disease?. In Psychology Bridging the Tasman: Science, Culture and Practice, Proceedings of the Joint Conference of the NZ Psychological Society and the Australian Psychological Society Vol. 58 (pp. 167). New Zealand: Australian Psychological Society. |
| 1997 | Cook, C. G., Andrews, J. M., Jones, K. L., Wittert, G. A., Chapman, I. M., Morley, J. E., & Horowitz, M. (1997). Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. In American Journal of Physiology Regulatory Integrative and Comparative Physiology Vol. 273 (pp. R755-R761). DOI Scopus122 |
| Year | Citation |
|---|---|
| 2021 | Kaazan, P., Ii, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2021). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI |
| 2021 | Barnes, A., Krishnaprasad, K., Carter, D., Walsh, A., Grafton, R., Hughes, J., . . . Andrews, J. (2021). Novel inflammatory bowel disease-specific electronic medical record allows scalable auditing of disease severity, therapy, complications, and the unmet need in care. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2020 | Kaazan, P., Li, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2020). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Andrews, J. M. (2019). Inflammatory bowel disease in older persons. Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY. |
| 2019 | Mikocka-Walus, A., Massuger, W., Knowles, S., Moore, G., Buckton, S., Connell, W., . . . Andrews, J. (2019). Patient experience of the quality of care for people with inflammatory bowel disease in Australia: A national survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Davis, R., Day, A., Bryant, R., Andrews, J., Barrett, J., Costello, S., & Vanlint, A. (2019). Habitual dietary fiber and prebiotic intake is inadequate in patients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2019 | Hrycek, C., Smart, C., Prosser, R., Lewis, H., Moss, K., Spizzo, P., . . . Mountifield, R. (2019). Consumer acceptability of a bespoke electronic medical record for inflammatory bowel disease is high and privacy concerns are reduced after education. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Hughes, P., Wardill, H., Dmochowska, N., Mavrangelos, C., Campaniello, M., Bowen, J., . . . Andrews, J. (2018). Proteolytic activation of IL-1 beta impairs epithelial barrier integrity in the ulcerative colitis lumen. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Brisbane, Qld: Wiley. |
| 2018 | Young, E., Lawrence, M., Thomas, M., & Andrews, J. (2018). Gastrointestinal adenocarcinoma in inflammatory bowel disease (IBD): What does it really "look" like? A retrospective review from a 10-year-old IBD service. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Lord, A. R., Baird, A., Simms, L. A., Hartnell, F., Krishnaprasad, K., Doecke, J., . . . Lawrance, I. C. (2018). Crohn's disease patients with at least one NOD2 mutation and who smoke regularly are four times as likely to need two or more resections. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2018 | Lord, A., Mortlock, S., Montgomery, G., Simms, L. A., Krishnaprasad, K., Hanigan, K., . . . Radford-Smith, G. L. (2018). Genetically distinct signatures of mild and severe ulcerative colitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. DOI |
| 2018 | Lord, A., Mortlock, S., Montgomery, G., Simms, L., Krishnaprasad, K., Hanigan, K., . . . Radford-Smith, G. L. (2018). GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS. Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC. DOI |
| 2018 | Lord, A., Baird, A., Simms, L., Krishnaprasad, K., Hanigan, K., Doecke, J. D., . . . Lawrance, I. (2018). CROHN'S DISEASE PATIENTS WITH AT LEAST 1 NOD2 MUTATIONS AND WHO SMOKE REGULARLY ARE FOUR TIMES AS LIKELY TO NEED TWO OR MORE RESECTIONS. Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2018 | Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Mogilevski, T., Flanagan, E., . . . Lawrance, I. (2018). VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC). Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC. |
| 2018 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. (2018). Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2018 | Krishnaprasad, K., Walsh, A., Begun, J., Bell, S., Carter, D., Grafton, R., . . . Andrews, J. (2018). Crohn's colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD). Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2018 | Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Mogilevski, T., Flanagan, E., . . . Lawrance, I. (2018). Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2017). Patients’ and clinicians’ views of and experience with a novel clinical pathway for functional gastrointestinal disorders. Poster session presented at the meeting of United European Gastroenterology Journal. Barcelona, Spain: Sage. |
| 2017 | Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2017). Performance of a diagnostic algorithm for functional gastrointestinal disorders. Poster session presented at the meeting of United European Gastroenterology Journal. Barcelona, Spain: Sage. |
| 2017 | Linedale, E. C., Mikocka-Walus, A., Vincent, A. D., Gibson, P. R., & Andrews, J. M. (2017). Performance of a diagnostic algorithm for functional gastrointestinal disorders. Poster session presented at the meeting of European Medical Journal Gastroenterology. EMG. |
| 2017 | Mikocka-Walus, A., Hughes, P., Bampton, P., Gordon, A., Campaniello, M., Mavrangelos, C., . . . Andrews, J. (2017). FLUOXETINE FOR MAINTENANCE OF REMISSION AND TO IMPROVE QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE: A PILOT RANDOMIZED PLACEBO-CONTROLLED TRIAL. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. |
| 2017 | Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2017). COGNITIVE BEHAVIOURAL THERAPY FOR INFLAMMATORY BOWEL DISEASE: 24-MONTH DATA FROM A RANDOMIZED CONTROLLED TRIAL. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. WoS1 |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Integrating psychological support into routine care for people with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Wardill, H., Bowen, J., Dmochowska, N., Campaniello, M., Mavrangelos, C., Holloway, R., . . . Hughes, P. (2017). Faecal supernatants from diarrhoea predominant Irritable Bowel Syndrome (IBS) patients disrupt colonic epithelial barrier function and directly activate colo-rectal afferent nerves. Poster session presented at the meeting of Abstracts of the NeuroGASTRO 2017 Congress, as published in Neurogastroenterology and Motility. Cork, Ireland: Wiley. DOI |
| 2017 | Wen, A., Selvanderan, S. P., Wu, Y., Xuan, W., Andrews, J. M., Koo, J. H., . . . Connor, S. (2017). Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. |
| 2017 | Wardill, H. R., Dmochowska, N., Campaniello, M. A., Mavrangelos, C., Bowen, J. M., Andrews, J. M., . . . Hughes, P. A. (2017). Fecal supernatants from active ulcerative colitis patients impair colonic epithelial barrier integrity and activate pelvic mucosal extrinsic afferent nerves. Poster session presented at the meeting of FASEB Journal. Chicago, IL: Federation of American Societies for Experimental Biology. |
| 2017 | Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2017). P577 "Treat to target" recommendations in ulcerative colitis in practice: clinician perceptions and potential barriers.. Poster session presented at the meeting of J Crohns Colitis. England: Oxford University Press (OUP). DOI |
| 2017 | Lawrance, I. C., Baird, A., Lightowler, D., Radford-Smith, G., Andrews, J. M., & Connor, S. (2017). OP007 A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2017 | Costello, S., Waters, O., Bryant, R., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. (2017). OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). P238 Mental health issues and healthcare utilisation in outpatients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. (2017). Clinical correlates of mental health issues in outpatients with Inflammatory Bowel Disease in routine care. Poster session presented at the meeting of European Crohn’s & Colitis Organisation’s 12th World Congress. Barcelona, Spain. |
| 2017 | Costello, S., Waters, O., Bryant, R., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. (2017). Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. WoS31 |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Mental health issues and healthcare utilisation in outpatients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Integrated psychological care in outpatients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Costello, S., Mashei, C., Bryant, R., Katsikeros, R., Waters, O., Makanyanga, J., . . . Andrews, J. (2017). Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis, healthy stool donors and the general Australian population. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Ben-Horin, S., Andrews, J. M., Katsanos, K. H., Rieder, F., Steinwurz, F., Karmiris, K., . . . Bernstein, C. N. (2017). Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practice. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2017). "Treat to target" recommendations in ulcerative colitis in practice: clinician perceptions and potential barriers. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2017 | Mavrangelos, C., Campaniello, M., Andrews, J., Bampton, P., & Hughes, P. (2017). Longitudinal analysis of IBS patients reveals that acquired immune responses are inhibited in symptom flare vs symptom free. Poster session presented at the meeting of Abstracts of the NeuroGASTRO 2017 Congress, as published in Neurogastroenterology and Motility. Cork, Ireland: Wiley. DOI |
| 2017 | Costello, S. P., Waters, O., Bryant, R. V., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. M. (2017). SHORT DURATION, LOW INTENSITY, POOLED FECAL MICROBIOTA TRANSPLANTATION INDUCES REMISSION IN PATIENTS WITH MILD-MODERATELY ACTIVE ULCERATIVE COLITIS: A RANDOMISED CONTROLLED TRIAL. Poster session presented at the meeting of GASTROENTEROLOGY. Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. DOI WoS37 |
| 2017 | Lores, T. J., Goess, C. S., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. M. (2017). Integrated psychological care in Inflammatory Bowel Disease outpatients: Early data from a new initiative.. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF INTEGRATED CARE. UBIQUITY PRESS LTD. DOI |
| 2016 | Goel, G., Mayassi, T., Qiao, S. -W., Ciszewski, C., King, T., Daveson, A. J., . . . Anderson, R. P. (2016). Sa1396 A Single Intradermal (ID) Injection of Nexvax2®, a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+ T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+ People With Celiac Disease (CeD). Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2016 | Goel, G., Andrews, J. M., Krause, R., Fogel, R., Barish, C. F., Daveson, A. J., . . . Anderson, R. P. (2016). Sa1395 Nexvax2®, a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+ People With Celiac Disease (CeD). Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2016 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. V. (2016). The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors. Poster session presented at the meeting of GASTROENTEROLOGY. San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. DOI WoS3 |
| 2016 | Campaniello, M., Mavrangelos, C., Bampton, P. A., Andrews, J. M., & Hughes, P. A. (2016). Expression of Gut Homing Markers on TReg Differs Between IBS and Remissive IBD. Poster session presented at the meeting of GASTROENTEROLOGY. San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. DOI |
| 2016 | Bye, W., Sparrow, M., Connor, S. J., Andrews, J. M., Watson Ng, W. S., Ellard, K., . . . Walsh, A. (2016). Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2016 | Lores, T., Goess, C., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. M. (2016). Routine psychological care in IBD outpatients: early data from a new initiative. Poster session presented at the meeting of 11th Congress of ECCO. Amsterdam, The Netherlands. |
| 2016 | Bryant, R. V., Costello, S. C., Schoeman, S., Sathananthan, D., Lau, S. Y., Schoeman, M. N., . . . Andrews, J. M. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2016 | Ferman, M., Hsieh, A. H. C., Brown, M., & Andrews, J. M. (2016). First use of vedoluzimab for steroid dependent immune mediated (ipilimumab) colitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2016 | Ferman, M., Glen, W. S., Hossain, M., & Andrews, J. M. (2016). Multidisciplinary team meetings: an effective process in managing patients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2016 | Bryant, R. V., Costello, S. C., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. M. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2016 | Lores, T., Goess, C., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. (2016). What is the need for, and acceptability of, routine, integrated psychological care in an established inflammatory bowel disease (IBD) service? Early data from a new initiative in clinical IBD care. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. WoS1 |
| 2016 | Bye, W., Sparrow, M., Connor, S. J., Andrews, J. M., Ellard, K., Ng, W., . . . Walsh, A. J. (2016). Identifying 'at-risk' inflammatory bowel disease patients who may be targeted with a new adjuvant herpes zoster subunit vaccine. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2016 | Mikocka-Walus, A., Andrews, J., Bampton, P., Hetzel, D., Hughes, P., & Esterman, A. (2016). Cognitive-behavioural therapy has no effect on disease activity but it improves quality of life in sub-groups of patients with inflammatory bowel disease short-term: a randomised controlled trial with a 24-month follow-up. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. WoS1 |
| 2016 | De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Gorelik, A., Liew, D., . . . Desmond, P. (2016). The first validated post-operative endoscopic Crohn's disease index: the POCER index-identification of key endoscopic prognostic factors. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. WoS1 |
| 2016 | Grafton, R., Hughes, J., Cronin, L., & Andrews, J. (2016). Proactive triaging of new patients into outpatient clinic improves outcomes at the Royal Adelaide Hospital Inflammatory Bowel Disease Service. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. |
| 2016 | Linedale, E. C., Shahzad, M., Mikocka-Walus, A., Gibson, P., & Andrews, J. M. (2016). How Can We Better Manage Functional Gastrointestinal Disease?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. DOI |
| 2015 | Costello, S., Mashei, C., & Andrews, J. (2015). Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis and healthy stool donors. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2015 | Shahzad, M. A., Linedale, E., Andrews, J. M., & Mikocka-Walus, A. A. (2015). Gastrointestinal outpatients referral quality: safe to use?. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley. DOI |
| 2015 | Linedale, E., Chur-Hansen, A., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2015). Diagnostic uncertainty signalled by specialists and ongoing investigations may contribute to patient insecurity in functional gastrointestinal disorders. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell. DOI |
| 2015 | Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2015). Could a structured screening approach be the answer to the avalanche of functional gastrointestinal disorder referrals? (An interim report). Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell. DOI |
| 2015 | Rizvi, Q., Linedale, E. C., Mikocka-Walus, A., Gibson, P., & Andrews, J. A. (2015). Do criteria to judge "appropriateness" of endoscopic procedures improve diagnostic yields or allow safe avoidance of upper gastrointestinal endoscopy? A retrospective review. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell. DOI |
| 2015 | Rizvi, Q., Linedale, E. C., Mikocka-Walus, A., Gibson, P., & Andrews, J. A. (2015). Can we better target colonoscopies using standard "appropriateness" guides?. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell. DOI |
| 2015 | Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., . . . Bell, S. J. (2015). Adalimumab and infliximab levels in neonates (ERA study). Poster session presented at the meeting of Abstracts of the 10th Congress of the European Crohn’s and Colitis Organisation (ECCO 2015) as published in Journal of Crohn's and Colitis. Barcelona, Spain: Oxford University Press. DOI |
| 2015 | Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2015) as published in Gastroenterology. Washington, D.C: Elsevier. DOI |
| 2015 | Wright, E. K., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Hamilton, A. L., . . . Singh, S. (2015). Tu1289 Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). 597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Sa1143 Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Chen, J. -H., Corte, C. J., Kariyawasam, V. C., Moran, N., Gounder, P., Collins, G. D., . . . Leong, R. W. (2015). Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Kjeldsen, J., . . . Bell, S. (2015). 540 Adalimumab and Infliximab Levels in Neonates (ERA Study). Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2015 | Pilichiewicz, A. N., Goess, C., Linedale, E., Ooi, S. J., Bryant, R. V., Grafton, R., . . . Andrews, J. M. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of Abstracts of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley. DOI |
| 2014 | Wright, E. K., De Cruz, P. P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). DOP086 Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study. Poster session presented at the meeting of Abstracts of the 9th Congress of the European Crohn’s and Colitis Organisation (ECCO 2014) as published in Journal of Crohn's and Colitis. Copenhagen, Denmark: Oxford University Press. DOI |
| 2014 | Kamm, M. A., De Cruz, P. P., Wright, E. K., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI WoS16 |
| 2014 | Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2014). P346 Short term dose tailoring of anti TNF-α therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2014 | Wright, E. K., De Cruz, P. P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). Faecal calprotectin is superior to faecal lactoferrin and S100A12. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI WoS2 |
| 2014 | Bennett, A., Moore, D., Bampton, P., & Andrews, J. (2014). P296 What happens to patients with paediatric onset inflammatory bowel disease (IBD) after transition to adult care and what is their view of the process?. Poster session presented at the meeting of Abstracts of the 9th Congress of the European Crohn’s and Colitis Organisation (ECCO 2014) as published in Journal of Crohn's and Colitis. Copenhagen, Denmark: Oxford University Press (OUP). DOI |
| 2014 | Costello, S., Ghaly, S., O'Connor, S., Agarwal, A., Beswick, L., Headon, B., . . . Andrews, J. (2014). P529 Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2014 | Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). 998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Heap, G. A., Singh, A., Bewshea, C. M., Weedon, M., Dubois, P., Andrews, J. M., . . . Ahmad, T. (2014). 6 Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease: Clinical Features and Genetic Determinants. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Bennett, A., Wichmann, M., Andrews, J. M., & Bampton, P. A. (2014). Su1098 Rural and Remote Care for Patients With Inflammatory Bowel Disease -Perceived Barriers Despite Good Non-Expert Practitioner Knowledge. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Ooi, S. -Y. J., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., Hughes, J. C., . . . Andrews, J. M. (2014). Mo1265 More Targeted Evaluation of Nutrition in Inflammatory Bowel Disease (IBD) Reveals Opportunities to Optimise Care: Body Mass Index, Body Composition and Iron Deficiency. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, I., Nguyen, N. Q., . . . Brierley, S. M. (2014). Distinct Alterations in the Guanylate Cyclase-C (GC-C)/Cyclic GMP (cGMP) Pathway Are Evident Across Different Subtypes of Irritable Bowel Syndrome (IBS) Patients. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2014) as published in Gastroenterology. Chicago, Illinois: Elsevier Science Direct. DOI |
| 2014 | Pilichiewicz, A. N., Holtmann, G., Goess, C., Holloway, R. H., Fraser, R. J., Beilby, J., . . . Andrews, J. M. (2014). Tu1844 Symptom Stability and Economic Burden in Patients With Functional Dyspepsia: Observational 12 Month Follow-Up After a Short-Term Clinical Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Hughes, P. A., Mikocka-Walus, A. A., Moretta, M., Pilichiewicz, A. N., Bampton, P. A., & Andrews, J. M. (2014). Mo1233 Cognitive Behavioural Therapy (CBT) Influences Innate and Adaptive Inflammatory Responsiveness in IBD Patients With Clinical Remission Sustained Over 6 Months: A Randomised Control Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2014 | Elnawsra, O., Fok, I., Connor, S., Sparrow, M., Gibson, P., & Andrews, J. M. (2014). Third party funding for Fecal Calprotectin is likely to reduce colonoscopy usage in Australia: Gastroenterologists' use and knowledge of its role in clinical practice. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2014) as published in Journal of Gastroenterology and Hepatology. Gold Coast, Queensland: Wiley. DOI |
| 2014 | Julsgaard, M., Christensen, L. A., Fallingborg, J., Gearry, R., Radford-Smith, G., Walsh, A., . . . Bell, S. J. (2014). DOP041 Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2014 | Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, I., Nguyen, N. Q., . . . Brierley, S. M. (2014). Distinct Alterations in the Guanylate Cyclase-C (GC-C)/Cyclic GMP (cGMP) Pathway Are Evident Across Different Subtypes of Irritable Bowel Syndrome (IBS) Patients. Poster session presented at the meeting of GASTROENTEROLOGY. Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. WoS3 |
| 2014 | Shah, A., Talley, N. J., Walker, M., Koloski, N., Shanahan, E. R., Morrison, M., . . . Holtmann, G. (2014). Is geographic variability of incidence and prevalence of Crohn's Disease linked to <i>Helicobacter pylori</i>? An ecologic study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2014 | Julsgaard, M., Christensen, L. A., Lawrence, I., Gearry, R., Connell, W., Grosen, A., . . . Bell, S. J. (2014). Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI WoS1 |
| 2014 | Julsgaard, M., Christensen, L. A., Gibson, P. R., Fallingborg, J., Gearry, R., Walsh, A., . . . Bell, S. J. (2014). Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. WoS1 |
| 2014 | Stephens, M., Hourigan, L. F., Appleyard, M., Ostapowicz, G., Schoeman, M., Desmond, P. V., . . . Holtmann, G. (2014). A systematic review of the performance and cost-efficiency of nurse and non-physician endoscopists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2014 | Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2014). Low muscle mass in inflammatory bowel disease (IBD): common and predictive of functional sarcopenia and osteopenia. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI |
| 2014 | Mikocka-Walus, A., Hughes, P., Moretta, M., Pilichiewicz, A., Long, H., Hetzel, D., . . . Andrews, J. (2014). Cognitive-behavioural therapy (CBT) improves inflammatory responsiveness but not mental health short term in IBD patients: A pilot randomised controlled trial. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. DOI WoS2 |
| 2014 | Bryant, R. V., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. M. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2014 | Harrington, A. M., Castro, J., Young, R. L., Kurtz, C., Silos-Santiago, A., Nguyen, N., . . . Brierley, S. M. (2014). Distinct alterations in the guanylate cyclase-C/cGMP pathway are evident across different subtypes of irritable bowel syndrome patients. Poster session presented at the meeting of Neurogastroenterology and Motility. Guangzhou, China: John Wiley and Sons. DOI |
| 2014 | Lim, A. H., Ooi, S. Y., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., . . . Andrews, J. M. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley. DOI |
| 2013 | Mikocka-Walus, A., Andrews, J., von Kaenel, R., & Moser, G. (2013). What are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?. Poster session presented at the meeting of PSYCHOTHERAPY AND PSYCHOSOMATICS. Lisboa, PORTUGAL: KARGER. |
| 2013 | McCallum, S., Mikocka-Walus, A., Turnbull, D., Gaughwin, M., & Andrews, J. (2013). The role of continuity of care (COC) in the treatment of comorbid mental health and substance use disorders (SUDs): A systematic review of the literature. Poster session presented at the meeting of Abstracts of the Inaugural Conference of the European Association of Psychosomatic Medicine (EAPM 2013) as published in the Journal of Psychosomatic Research. Homerton College, Cambridge, UK: Elsevier. DOI |
| 2013 | Hughes, P. A., Moretta, M., Bird, D., Grasby, D., Lim, A., Brierley, S. M., . . . Krumbiegel, D. (2013). Beta-endorphin secretion by monocyte/macrophages is deficient in irritable bowel syndrome: a contributor to visceral hypersensitivity?. Poster session presented at the meeting of NEUROGASTROENTEROLOGY AND MOTILITY. WILEY-BLACKWELL. |
| 2013 | Hughes, P., Moretta, M., Lim, A., Grasby, D., Bird, D., Bampton, P., . . . Krumbiegel, D. (2013). Lack of macrophage/monocyte derived β-endorphin contributes toward sensations of pain/discomfort in Irritable Bowel Syndrome. Poster session presented at the meeting of JOURNAL OF IMMUNOLOGY. Honolulu, HI: AMER ASSOC IMMUNOLOGISTS. |
| 2013 | Roberts, M. B., Selinger, C. P., Leong, R. W. L., & Andrews, J. M. (2013). Poor Inflammatory Bowel Disease (IBD)-specific pregnancy knowledge in patients with Inflammatory Bowel Disease: predictive factors and implications. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week 2013, as published in Journal of Gastroenterology and Hepatology. Melbourne, Victoria: Wiley-Blackwell. DOI |
| 2013 | Rahman, A. H. A., Low, I. W., Chan, F., Rizvi, Q. A., Schoeman, M. N., Harley, H. A. J., . . . Holloway, R. H. (2013). Urgent endoscopy for oesophageal variceal bleeding: does it matter?. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in the Journal of Gastroenterology and Hepatology. Melbourne, Victoria: Wiley. |
| 2013 | Costello, S., Ghaly, S., Beswick, L., Pudipeddi, A., Agarwal, A., Headon, B., . . . Andrews, J. M. (2013). Compassionate access use of Anti-TNF therapy in Ulcerative Colitis in four Australian IBD centres has been beneficial to patient outcomes. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2013 | Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. M. (2013). Compassionate access use of anti-TNF therapy in Crohn's disease reduces the need for steroids in an Australian multicenter retrospective review. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2013 | Lunney, P., Kariyawasam, V., Middleton, K., Wang, R., Huang, T., Selinger, C., . . . Leong, R. (2013). P614 Smoking prevalence and its effects on disease course and surgery in a cohort of inflammatory bowel disease patients from Sydney, Australia. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Mikocka-Walus, A., & Andrews, J. (2013). P320 What's the evidence-base for treating mental health co-morbidities in IBD?. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Roberts, M., Selinger, C., Leong, R., & Andrews, J. (2013). P586 Assessment of pregnancy-specific inflammatory bowel disease (IBD) knowledge, attitudes and experience in Australian obstetricians and gynaecologists (O&G). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Bryant, R., Schultz, C., Grafton, R., Hughes, J., Goess, C., Schoeman, M., . . . Andrews, J. (2013). P375 Sarcopaenia in inflammatory bowel disease (IBD), a prominent finding in males with normal BMI: What are we missing?. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Lawrance, I., Murray, K., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., . . . Hanigan, K. (2013). P365 Smoking and the effect of its cessation on Crohn's disease progression and surgical rates. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Hughes, J., Andrews, J., & Grafton, R. (2013). N004 Successful, nurse-led, protocol-based, safety monitoring in IBD patients on thiopurines. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Kariyawasam, V., Lunney, P., Huang, T., Middleton, K., Wang, R., Selinger, C., . . . Leong, R. (2013). P631 Natural history of elderly onset inflammatory bowel disease – Sydney IBD Cohort (1942–2012). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2013 | Kariyawasam, V. C., Lunney, P. C., Huang, T. D., Middleton, K., Wang, R. R., Selinger, C. P., . . . Leong, R. W. (2013). 39 Early Treatment With Immunomodulators Is Associated With Change in the Natural History of Inflammatory Bowel Disease - Multicentre Longitudinal Study -Sydney, Australia 1942-2012. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). 925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study.. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Bryant, R. V., Schultz, C. G., Grafton, R., Hughes, J. C., Goess, C., Schoeman, M., . . . Andrews, J. M. (2013). Mo1311 Body Mass Index (BMI) Is Better At Predicting Fat Mass Than Muscle Mass in Inflammatory Bowel Disease (IBD) Patients. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Pilichiewicz, A. N., Andrews, J. M., Goess, C., Holloway, R. H., Fraser, R. J., Beilby, J., . . . Holtmann, G. (2013). Mo1871 A 12 Month Follow-up of Patients Complying With ROME III Criteria for FD: Symptom Stability and Economic Burden. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Pan, W. -J., Radford-Smith, G., Andrews, J. M., Schwartz, H. I., Sullivan, B. A., Evangelista, C. M., . . . Borie, D. C. (2013). Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Kashkooli, S., Roberts, M. B., Selinger, C. P., Weston, M. J., Andrews, J. M., & Leong, R. W. (2013). Mo1279 Pregnancy-Related Inflammatory Bowel Disease Knowledge Amongst Obstetricians Is Significantly Lower Than Gastroenterologists. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Mountifield, R. E., Bampton, P. A., Prosser, R., Bobridge, A., Mikocka-Walus, A. A., & Andrews, J. M. (2013). Mo1962 FIT+ and IBD Individuals Have Differing Psychological Reactions to the Need for Colonoscopy. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, A., Nguyen, N. Q., . . . Brierley, S. M. (2013). 268 Alterations in the Guanylate Cyclase-C/cGMP Pathway in Patients With Irritable Bowel Syndrome With Constipation. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Holtmann, G., Andrews, J. M., Holloway, R. H., Beilby, J., Adam, B., Pilichiewicz, A. N., . . . Talley, N. J. (2013). Mo2071 A Placebo Controlled Randomised Treatment Trial for Functional Dyspepsia Including Post-Treatment Drug Withdraw and Placebo Withdraw Effects. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2013 | Mikocka-Walus, A. A., Andrews, J. M., Von Kanel, R., & Moser, G. (2013). 246 What are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?. Poster session presented at the meeting of Abstracts of the 22nd World Congress on Psychosomatic Medicine: Psychosomatic Assessment and Integrative Care (ICPM 2013)as published in Psychotherapy and Psychosomatics. Karger Publishers. |
| 2013 | De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Strategic timing of anti-TNF therapy in postoperative Crohn's disease: Comparison of routine use immediately postoperatively with selective use after demonstrated recurrence at 6 month endoscopy. Results from POCER. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley. DOI |
| 2013 | De Cruz, P., Kamm, M., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Smoking is the key risk factor that doubles the risk of postoperative recurrence of Crohn's disease despite preventive drug treatment. Results from the POCER study. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013), as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley. DOI |
| 2013 | Bennett, A., Wichmann, M. W., Andrews, J. M., & Bampton, P. A. (2013). Rural IBD patients' access to care, rural surgeons' and IBD nurses' perspectives: Good practitioner knowledge, but significant barriers to optimal care. Poster session presented at the meeting of Abstracts of Journal of Australian Gastroenterology Week (AGW 2019) as published in Gastroenterology and Hepatology. Melbourne, Australia: Wiley. |
| 2013 | Julsgaard, M., Christensen, L. A., Gearry, R., Andrews, J. M., Rosella, O., Connor, S., . . . Bell, S. J. (2013). Intra-uterine exposure to anti-TNF-alpha therapy (ERA study): Neonatal levels of TNF antibodies correlate with duration of therapy in pregnancy. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley. DOI |
| 2012 | Lunney, P. C., Middleton, K. L., Wang, R. R., Andrews, J. M., Kariyawasam, V. C., Peat, J., . . . Leong, R. W. (2012). Smoking prevalence in inflammatory bowel disease and its effects on disease course and surgery. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Kariyawasam, V. C., Wang, R. R., Middleton, K. L., Lunney, P. C., Selinger, C. P., Collins, G. D., . . . Leong, R. W. (2012). Surgical resection rate of Crohn's disease over time: the Sydney Inflammatory Bowel Disease Cohort (1942-2012). Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Kariyawasam, V. C., Middleton, K. L., Lunney, P. C., Wang, R. R., Andrews, J. M., Selinger, C. P., . . . Leong, R. W. (2012). The natural history of ulcerative colitis and predictors of the use of immunomodulators and colectomy: the Sydney Inflammatory Bowel Disease Cohort 1946-2012. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Kariyawasam, V. C., Lunney, P. C., Wang, R. R., Middleton, K. L., Selinger, C. P., Katelaris, P., . . . Leong, R. W. (2012). Natural history of Crohn's disease and changes in the use of immunomodulators over time: the Sydney inflammatory bowel disease cohort 1942-2012. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Agarwal, A., & Andrews, J. M. (2012). IBD-related pyoderma gangrenous in the biologic era: a single centre, 5-year case series and systematic literature review. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | De Cruz, P., Kamm, M., Hamilton, A. L., Ritchie, K., Gorelik, A., Liew, D., . . . Desmond, P. V. (2012). P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: Early results from the prospective POCER study. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2012 | Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. M. (2012). P271 A magic pill? Patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2012 | Selinger, C., Andrews, J. M., Dent, O., & Leong, R. (2012). P082 Survival over >20 years in a large Australian metropolitan cohort of inflammatory bowel disease patients: No excess overall mortality. Poster session presented at the meeting of Abstracts of the 7th Congress of the European Crohn’s and Colitis Organisation (ECCO 2012) as published in Journal of Crohn's and Colitis. Barcelona, Spain: Oxford University Press (OUP). DOI |
| 2012 | Hartnell, F., Jones, L., Bampton, P., Krishnaprasad, K., Grafton, R., Cooke, S., . . . Radford-Smith, G. (2012). P372 Predicting long-term response to anti-TNFα in Crohn's disease. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2012 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Pilichiewicz, A. N., Andrews, J. M., Goess, C., McMahon, J., Barrett, B., Fraser, R. J., . . . Holtmann, G. (2012). Su1633 Placebo Effects in Functional Dyspepsia: A Preliminary Analysis on Symptoms in an Ongoing Randomized Placebo Controlled Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Pilichiewicz, A. N., Persson, J., Goess, C., Gapasin, J. D., Tsopelas, C., Bartholomeusz, D., . . . Andrews, J. M. (2012). Sa2068 The Effect of the Probiotic Escherichia coli Nissle 1917 on Symptom Patterns and Immune Response in Patients Suffering From Diarrhoea Predominant Irritable Bowel Syndrome. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Huynh, D., Bate, J. P., Andrews, J. M., Johnson, R., LeMire, M., Nind, G., & Harley, H. A. (2012). Mo1890 Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Radford-Smith, G., Hartnell, F., Jones, L. V., Krishnaprasad, K., Prosser, R., Marr, D., . . . Gearry, R. B. (2012). Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Radford-Smith, G., Krishnaprasad, K., Andrews, J. M., Bampton, P. A., Simms, L., Mahy, G., . . . Lawrance, I. C. (2012). Sa1282 Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2012 | Hughes, P. A., Bird, D., Brierley, S. M., Persson, J., Moretta, M., Blackshaw, L. A., . . . Andrews, J. M. (2012). TNF-alpha from gut homing memory T cells and monocytes sensitises colonic sensory afferents in IBS-D. Poster session presented at the meeting of Neurogastroenterology and Motility: Supplement. Bologna, Italy: WILEY-BLACKWELL. |
| 2012 | Wright, E., Andrews, J. M., Bampton, P. A., Moore, D., Williams, J., Lemberg, D. A., . . . De Cruz, P. (2012). Perspectives on transfer and transition care of adolescents with inflammatory bowel disease (IBD) from paediatric to adult care: a survey of paediatric and adult gastroenterologists in Australia and New Zealand. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. |
| 2012 | Selinger, C. P., Andrews, J. M., Titman, A. C., & Leong, R. W. (2012). The natural history of Crohn's disease: need for initial and further resectional surgery. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Selinger, C. P., Andrews, J. M., Titman, A. C., & Leong, R. W. (2012). Low incidence of colorectal cancer in Australian ulcerative colitis patients. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Middleton, K. L., Kariyawasam, V. C., Lunney, P. C., Wang, R. R., Selinger, C. P., Katelaris, P., . . . Leong, R. W. (2012). A comparison of inflammatory bowel disease patients aged with disease and those diagnosed late in life. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. DOI |
| 2012 | Pilichiewicz, A. N., Holtmann, G., Goess, C., Holloway, R., Fraser, R. J., Beilby, J., . . . Andrews, J. (2012). Symptoms and disease burden in patients with functional dyspepsia: an observational 12 month follow-up. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2012 | Mikocka-Walus, A., Turnbull, A., Holtmann, G., & Andrews, J. (2012). THE INTEGRATED MODEL OF CARE FOR INFLAMMATORY BOWEL DISEASE SUFFERERS IN AUSTRALIA: THE DEVELOPMENT OF THE PROTOCOL AND THE EFFECTS OF ITS IMPLEMENTATION. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. SPRINGER. |
| 2012 | Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley. DOI |
| 2012 | Kashkooli, S. B., Selinger, C., Weston, M. J., Roberts, M. B., Andrews, J., Leong, R. W., & Akbarzadeh, S. (2012). Pregnancy-related inflammatory bowel disease knowledge amongst obstetricians is significantly lower than gastroenterologists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2012 | Roberts, M. B., Selinger, C., Leong, R. W., & Andrews, J. (2012). Assessment of pregnancy-specific inflammatory bowel disease (IBD) knowledge, attitudes and experience in obstetricians and gynaecologists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2012 | Hughes, P., Nicholson, I., Bird, D., To, S., Isaacs, N., Grasby, D., . . . Krumbiegel, D. (2012). C-IBS patients lack monocyte derived β-endorphin which results in disinhibition of colonic afferent mechanosensitivity. Poster session presented at the meeting of Gastroenterology. USA: WB Saunders. DOI |
| 2011 | Hughes, P., Harrington, A., Brierley, S., Maldeniya, M., Martin, C., Persson, J., . . . Blackshaw, L. (2011). Cytokine modulation of visceral afferents via cation channels is switched in chronic visceral hypersensitivity. Poster session presented at the meeting of Gastroenterology. Chicago, IL: W B Saunders Co. DOI |
| 2011 | Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). INPATIENT HEALTH CARE UTILISATION ALCOHOLIC LIVER DISEASE: WHAT ARE THE COSTS AND OUTCOMES?. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Berlin, GERMANY: ELSEVIER. DOI |
| 2011 | Persson, J., Pilichiewicz, A. A., Gapasin, J., Goess, C., Holtmann, G. J., Holloway, R., & Andrews, J. M. (2011). Immune response in patients with diarrhoea predominant irritable bowel syndrome following Escherichia coli Nissle 1917, mutaflor treatment. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2011 | Pilichiewicz, A. N., Persson, J., Goess, C., Gapasin, J., Holtmann, G. J., Holloway, R. H., & Andrews, J. M. (2011). The effect of the probiotic Escherichia coli Nissle 1917 on symptom patterns in patients suffering from diarrhoea predominant irritable bowel syndrome. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. |
| 2011 | Pilichiewicz, A. N., Andrews, J. M., Goess, C., Mcmahon, J., Fraser, R. J., Beilby, J., . . . Holtmann, G. (2011). A preliminary analysis of the effect Iberogast®, Nexium, dual Iberogast® plus Nexium or dual placebo on symptoms in patients with functional dyspepsia. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. WoS3 |
| 2011 | Asser, T. L., Kennedy, N. A., Bampton, P. A., Andrews, J. M., Elliott, D., & Doogue, M. (2011). The effect of allopurinol on thiopurine metabolite concentrations in patients with inflammatory bowel disease. Poster session presented at the meeting of Abstracts of the 6th Congress of the European Crohn’s and Colitis Organisation (ECCO 2011). Dublin, Ireland: ECCO. |
| 2011 | Kennedy, N. A., Doogue, M., Andrews, J. M., Asser, T. L., & Bampton, P. A. (2011). P268. Thiopurine metabolite measurement and the management of inflammatory bowel disease in South Australia: The first 18 months. Poster session presented at the meeting of 6th Congress of ECCO. Dublin. |
| 2011 | De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Prideaux, L., Lawrance, I. C., . . . Connell, W. (2011). Prospective evaluation of early post-operative Crohn's recurrence in the presence of optimal drug therapy - Is Endoscopic Evaluation Worthwhile?. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier. DOI |
| 2011 | Haag, S., Andrews, J. M., Gapasin, J. D., Keller, A., & Holtmann, G. (2011). The influence of socioeconomic status on the prevalence of upper gastrointestinal symptoms: a 13-Nation Population Survey. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier. DOI |
| 2011 | Lawrance, I. C., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., Andrews, J. M., . . . Croft, A. (2011). Smoking cessation following the diagnosis of Crohn's Disease still reduces the rates of surgery and complicated disease. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011), as published in Gastroenterology. Chicago, IL: Elsevier. DOI WoS1 |
| 2011 | Mikocka-Walus, A. A., Turnbull, D. A., Holtmann, G., & Andrews, J. M. (2011). Coping with the unmet needs of gastroenterology and hepatology outpatients: a systematic approach towards an integrated model of care in South Australia. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier. DOI WoS2 |
| 2011 | Mountifield, R. E., Moseley, A., Prosser, R., Mikocka-Walus, A. A., Young, G., Andrews, J. M., & Bampton, P. A. (2011). Colonoscopic bowel cancer screening is associated with more depression and anxiety in previously healthy people than those with inflammatory bowel disease. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier. DOI WoS1 |
| 2011 | Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). 507 INPATIENT HEALTH CARE UTILISATION ALCOHOLIC LIVER DISEASE: WHAT ARE THE COSTS AND OUTCOMES?. Poster session presented at the meeting of Journal of Hepatology. Elsevier BV. DOI |
| 2011 | Walker, N. M., Andrews, J. M., Walsh, A. J., & Radford-Smith, G. (2011). Ulcerative colitis management: a survey on current practice by Australian gastroenterologists. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2011) as published in Journal of Gastroenterology and Hepatology. Brisbane Convention & Exhibition Centre, Australia: Wiley. DOI |
| 2011 | Selinger, C. P., Bath, S., Andrews, J. M., Dent, O., & Leong, R. W. (2011). Mortality in a large Australian metropolitan cohort of Crohn's disease patients. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2011) as published in Journal of Gastroenterology and Hepatology. Brisbane Convention & Exhibition Centre, Australia: Wiley. DOI |
| 2011 | Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). Inpatient health care utilisation in alcoholic liver disease: what are the costs and outcomes?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Brisbane, Qld: Wiley. DOI |
| 2010 | mikocka-Walus, A. A., Bond, M., Holloway, R. H., Burke, A. L. J., Collins, K., Blackshaw, L. A., . . . Andrews, J. A. (2010). Does Cognitive Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of European Crohn’s and Colitis Organisation, 5th ECCO Congress, Inflammatory Bowel Diseases. Prague, Czech republic. |
| 2010 | Mikocka-Walus, A. A., Bond, M., Holloway, R. H., Persson, J., Pilichiewicz, A. N., Hughes, P. A., . . . Andrews, J. M. (2010). T1253 Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Van Langenberg, D. R., & Andrews, J. M. (2010). W1319 Predictors of Suboptimal Medication Adherence in IBD Patients: A Single Australian Tertiary Centre Experience. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Paterson, J., Grafton, R., Van Langenberg, D. R., & Andrews, J. M. (2010). 761 The Effect of Perianal Disease on Perceived Severity of Crohn's Disease (CD). Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Pilichiewicz, A. N., Holtmann, G., Persson, J., Gapasin, J., Holloway, R. H., Goess, C., . . . Andrews, J. M. (2010). S1339 A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Gururatsakul, M., Andrews, J. M., Holtmann, G., Talley, N., & Holloway, R. H. (2010). T1089 Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia?. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Phan, V. -A., van Langenberg, D. R., Grafton, R., & Andrews, J. M. (2010). M1037 Introduction of a Dedicated IBD Service Quantitatively and Qualitatively Improves Outcomes in Less Than 18 Months: A Prospective Cohort Study in a Large Metropolitan Centre. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Mikocka-Walus, A. A., van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2010). S1016 Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2010 | Pilichiewicz, A. N., Holtmann, G., Goess, C., Mcmahon, J., Fraser, R. J., Beilby, J., . . . Andrews, J. M. (2010). Recruiting to a functional dyspepsia clinical trial:-where have all the patients gone?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). Inflammatory Bowel Disease (IBD) patients' assessment and regulation of their diet in relation to symptom recurrence. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Haag, S., Andrews, J. M., Gapasin, J., Gerken, G., Keller, A., & Holtmann, G. (2010). A 13-nation population survey of upper gastrointestinal symptoms: the impact of socioeconomic status. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). The importance of patient perception of personalised care in the provision of specialist care for patients with Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Sack, C., Phan, V. A., Grafton, R., Van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2010). The introduction of a formal IBD service reduces healthcare utilisation and disease burden indicators (complexity measures) in IBD patients. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Mikocka-Walus, A., Holtmann, G., & Andrews, J. (2010). A South Australian integrated model of care for Inflammatory Bowel Disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Stewart, B. J., Mikocka-Walus, A., Harley, H., Morgan, J., Colman, A., Phelps, M., & Andrews, J. M. (2010). Psychosocial and mental health issues surrounding chronic hepatitis C: patient, hepatologist and counsellor perspectives. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2010 | Mikocka-Walus, A. A., Bond, M., Holloway, R. H. H., Pilichiewicz, A., Persson, J., Collins, K., . . . Andrews, J. M. (2010). Cognitive behavioural therapy (CBT) as a treatment modality in inflammatory bowel disease (IBD): early experience and preliminary results. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. WoS1 |
| 2010 | Doecke, J., Simms, L. A., Zhao, Z. Z., Huang, N., Hanigan, K., Croft, A., . . . Radford-Smith, G. L. (2010). Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. WoS1 |
| 2010 | Crocker, K. M., Chur-Hansen, A., Bampton, P., & Andrews, J. M. (2010). A comparison of sexual dysfunction in functional bowel disorders and inflammatory bowel disease: does the diagnosis make a difference to patients?. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2010) as published in the Journal of Gastroenterology and Hepatology. Gold Coast, Queensland: Wiley. |
| 2009 | Andrews, J. M., Mikocka-Walus, A. A., Hetzel, D. J., & Holtmann, G. (2009). P113 - Interactions among treatment trends, quality of life and disease activity in inflammatory bowel disease (IBD). Poster session presented at the meeting of Abstracts of the 4th Congress of the European Crohn’s and Colitis Organisation (ECCO 2009) as published in Journal of Crohn's and Colitis. Hamburg, Germany: Oxford University Press (OUP). DOI |
| 2009 | Gapasin, J., van Langenberg, D. M., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). P172 - In what proportion of IBD patients coming to resection surgery was there an opportunity to optimise preoperative care? A one year audit of a tertiary referral hospital. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP). DOI |
| 2009 | Zschau, N. B., Andrews, J. M., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Holtmann, G. (2009). M1912 Do Socioeconomic Status and Lifestyle Factors Predict Symptomatic Improvement Over 8 Weeks in Patients with Gastroesophageal Reflux Symptoms in the Routine Clinical Setting? - the MAPSOMAL Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Knott, V. E., Holtmann, G., Turnbull, D. A., & Andrews, J. M. (2009). M1253 Patients' Satisfaction with Specialist Gastroenterologist Consultation for Irritable Bowel Syndrome (IBS)and Health Care Utilisation: Exploring the Role of Patient Expectations. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Mountifield, R. E., Bampton, P. A., Prosser, R., Muller, K. R., & Andrews, J. M. (2009). S1118 Pregnancy, Disease Activity and IBD Medication: This Two-Edged Sword from a Patient Perspective. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Van Langenberg, D. R., Bryant, R. V., Holtmann, G., & Andrews, J. M. (2009). S1034 Symptoms of Functional Gastrointestinal Disorders (FGIDs) in IBD Patients and the Inter-Relationships of Psychological Co-Morbidity, Quality of Life and Disease Activity. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Florin, T. H. (2009). S1102 Serious Infective Complications in Anti-TNFα Treated Inflammatory Bowel Disease Patients. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Haag, S., Andrews, J. M., Gapasin, J. D., Keller, A., & Holtmann, G. (2009). 970 A 13-Nation Population Survey of Upper Gastrointestinal Symptoms: Age and Gender. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Adam, B., Liebregts, T., Zschau, N. B., Faraguna, L. -A., Gapasin, J. D., Andrews, J. M., . . . Holtmann, G. (2009). T1266 Z-338 Improves Meal-Induced Symptoms in Functional Dyspepsia: A Double-Blind, Randomized, Placebo Controlled Crossover Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Zschau, N. B., Holtmann, G., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Andrews, J. M. (2009). M1852 Do Concomitant Functional Dyspepsia and Irritable Bowel Syndrome Influence Changes in Quality of Life in Patients with Gastroesophageal Reflux Symptoms Referred for Endoscopy? - the MAPSOMAL Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Farrall, E., Collins, J., Turnbull, D. A., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). M1249 Do We Know What Patients Want? the Communication/Understanding Gap Between Patients with Functional Gastrointestinal Disorders (FGIDs) and Gastroenterologists. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2009 | Alshumrany, M. A., Van Langenberg, D. R., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). W1111 Comparative Complexity of Crohn's Disease (CD) Compared to Ulcerative Colitis (UC) in a Metropolitan Hospital Setting. Effects of Gender and Disease Activity. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2008 | Mountifield, R. E., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). W1136 Fear and Fertility in Inflammatory Bowel Disease - A Mismatch of Perception and Reality Affects Patient Behaviour. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008) as published in Gastroenterology. San Diego, California: Elsevier Science Direct. DOI |
| 2008 | Zschau, N. B., Tam, W., Andrews, J. M., Holloway, R. H., Schoeman, M., & Holtmann, G. J. (2008). T2015 Multivariate Analysis of Predictors for Severity of Mucosal Lesions in Patients with GERD Symptoms (Mapsomal): A Clinical, Epidemiological and Endoscopic Survey. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008) as published in Gastroenterology. San Diego, California: Elsevier. DOI |
| 2008 | Mikocka-Walus, A. A., Andrews, J. M., Turnbull, D. A., Wilson, I. G., & Holtmann, G. J. (2008). T1172 Psychological Co-Morbidity and Quality of Life (Qol) Vary Between Inflammatory Bowel Disease (IBD) Cohorts in Different Regions and Amongst IBD and Other Chronic Diseases in the One Region. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2008 | Knott, V. E., Andrews, J. M., Turnbull, D. A., & Holtmann, G. J. (2008). T1025 IBS and Outpatient Services: Towards the Development of An Empirical Model of Health Care Utilisation. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2008 | Muller, K. R., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). 944 Female Gender and Surgery Lead to Greater Perceived Impact of Inflammatory Bowel Disease (IBD) On Body Image and Sexual Function: A Neglected Issue. Poster session presented at the meeting of Gastroenterology. Elsevier BV. DOI |
| 2008 | Steveling, K., Holtmann, G. J., Schoeman, M., & Andrews, J. M. (2008). Appropriateness and Diagnostic Yield of Colonoscopy in Young Women. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008), as published in Gastrointestinal Endoscopy. San Diego, California: Mosby. DOI |
| 2008 | Andrews, J. M., Mikocka-Walus, A. A., Turnbull, D. A., Hetzel, D. J., & Holtmann, G. J. (2008). T1171 Concomitant Symptoms of Functional Gastrointestinal Disorders (FGIDs) in Patients with Inflammatory Bowel Disease (IBD) Are Associated with Decreased Quality of Life (Qol). Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008), as published in Gastroenterology. San Diego, California: Elsevier. DOI |
| 2008 | Van Langenberg, D. R., Lange, K., Hetzel, D. J., Holtmann, G., & Andrews, J. M. (2008). Psychiatric comorbidities and prior surgery are associated with poorer outcomes in IBD patients. Poster session presented at the meeting of Proceedings of the 2008 Australian Gastroenterology Week, as published in Journal of Gastroenterology and Hepatology. Brisbane, QLD: Wiley. DOI |
| 2008 | Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Radford-Smith, G. L. (2008). Serious infective complications associated with anti-TNF alpha therapy in inflammatory bowel disease. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2008) as published in Journal of Gastroenterology and Hepatology. Brisbane, Australia: Wiley. WoS2 |
| 2008 | Langenberg, V., Simon, S. J., Holtmann, G., & Andrews, J. M. (2008). IBD patients and healthcare utilisation: gastroenterologists do make a difference!. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2008) as published in Journal of Gastroenterology And Hepatology. Brisbane, Australia: Wiley. |
| 2008 | Bertram, S., Van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2008). Do inflammatory bowel disease (IBD) responders differ from nonresponders to a postal questionnaire? Implications for generalisability. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. WoS1 |
| 2008 | Farrall, E., Collins, J., Turnbull, D. A., Hetzel, D. J., Holtmann, G., & Andrews, J. M. (2008). Do we know what patients want? The under-recognised needs of patients with functional gastrointestinal disorders (FGID). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2008 | Mikocka-Walus, A. A., Turnbull, D. A., Andrews, J. M., Moulding, N. T., Wilson, I. G., & Holtmann, G. J. (2008). Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. |
| 2006 | Mountifield, R. E., Andrews, J. M., Fraser, R. J., Heddle, R., Hebbard, G. S., & Checklin, H. (2006). How does age affect manometric diagnosis in patients with dysphagia?. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2006), as published in Journal of Gastroenterology and Hepatology. Adelaide, Australia: Wiley. DOI |
| 2001 | Andrews, J. M., O'Donovan, D. G., Hebbard, G. S., Doran, S. M., Malbert, C. H., & Dent, J. (2001). Human duodenal phase III MMC activity is not predominantly retroperistaltic. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2001) and the 102nd Annual Meeting of the American Gastroenterological Association, as published in Gastroenterology. Atlanta, G.A: Elsevier. DOI |
| 2000 | Jones, K. L., Berry, M. K., Andrews, J., MacIntosh, C., & Horowitz, M. (2000). Effects of cisapride on antral area and fullness during intraduodenal lipid infusion. Poster session presented at the meeting of Gastroenterology. San Diego, CA: Elsevier. DOI |
| 1998 | Andrews, J. M., Rayner, C. K., Doran, S. M., & Horowitz, M. (1998). Variations of blood glucose in the physiological range alter appetite, gastrointestinal sensation, and pyloric motility. Poster session presented at the meeting of Abstracts of the American Gastroenterological Association and Digestive Disease Week (DDW 1998) as published in Gastroenterology. New Orleans, Louisiana: Elsevier. DOI |
| 1998 | Verhaaen, M. A. M. T., Rayner, C. K., Andrews, J. M., Doran, S. M., Hebbard, G. S., Samsom, M., & Horowitz, M. (1998). Effect of physiological changes in blood glucose on proximal gastric motor and sensory function. Poster session presented at the meeting of Abstracts of the Netherlands Society of Gastroenterology and the Netherlands Society of Hepatology: Spring Meeting, 19–20 March 1998. Lippincott Williams. DOI |
| Date | Project Title | Role | Funding Body | Amount |
|---|---|---|---|---|
| 2016 | Exploring the role of diet as an Adjunctive Therapy in Ulcerative Colitis (EAT-UC Study) | CIC | RAH Research Foundation | $18,640 |
| 2015-17 | Faecal Microbiota Transplantation for Active Ulcerative Colitis - a randomised controlled trial: clinical, microbial and immune outcomes | CIA | NHMRC | $765,896 |
| 2015-16 | Psychological care in routine IBD practice | CIA | GESA/Janssen | $125,000 |
| 2014-16 | FMT in ulcerative colitis | CIA | GUTSY Foundation | $150,000 |
| 2013-15 | Immune function in functional GI disorders | AI | NHMRC | $454,369 |
| 2013-14 | Low dose fluoxetine in Crohn’s disease | CIB | Broad Foundation US | $128,000 |
| 2013-14 | RIBG | CIA | RAH Research Foundation | $67,000 p.a |
| 2013 | Transition Care Outcomes of Paediatric patients with IBD After Entering Adult Medical care | CIA | Abbott Australia | $40,000 |
| 2013 | IBD disease Burden in Rural and Remote Patients | CIB | Janssen Australia | $50,000 |
| 2012-14 | Genomic medicine: Predictors of refractory ulcerative colitis and its response to treatment | CID | NHMRC | $849,263 |
| 2012 | CBT in IBD study | CIA | Abbott Australia | $50,000 |
| 2010-11 | Does Cognitive Behavioural Therapy (CBT) prolong remission in IBD? | CIB | Crohn’s and Colitis Australia | $150,000 |
| 2009 | Investigation of factors influencing patient satisfaction or dissatisfaction with medical and surgical care in IBD | CIA | RAH | $20,000 |
- Accredited Supervisor, Examiner and Site Visitor for Advanced Training in Gastroenterology, Royal Australian College of Physicians 2006-current
- Coordinator of undergraduate and postgraduate teaching within clinical gastroenterology & hepatology @ RAH 2009-current
- Clinical Ward Teaching, Gastroenterology Unit 4-6th year University of Adelaide Undergraduate Medical Students, 2007-present & coordinator of GE afternoon core program 2009-current
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 | External Supervisor | - | Doctor of Philosophy | Doctorate | Full Time | Ms Lucie Anne Marsh-Smith |
| 2023 | Co-Supervisor | The impact of obesity and adiposity on inflammatory bowel disease | Master of Clinical Science | Master | Part Time | Dr Patricia Kaazan |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 - 2025 | Co-Supervisor | Barriers and Enablers to Bariatric Surgery in Australia and New Zealand | Doctor of Philosophy | Doctorate | Full Time | Miss Mia Majstorovic |
| 2021 - 2024 | Principal Supervisor | Defining and validating the role of intestinal ultrasound for assessment of inflammatory bowel disease | Doctor of Philosophy | Doctorate | Full Time | Dr Tom Goodsall |
| 2020 - 2022 | Co-Supervisor | Gut microbiome insights into the pathophysiology of inflammatory bowel disease | Doctor of Philosophy | Doctorate | Full Time | Miss Gina Lucille Guzzo |
| 2018 - 2021 | Principal Supervisor | Exploring a patient-centred, diet-focused treatment paradigm for Inflammatory Bowel Disease | Doctor of Philosophy | Doctorate | Full Time | Mrs Alice Sarah Day |
| 2015 - 2018 | Principal Supervisor | Improving Quality of Care in Inflammatory Bowel Disease: Treatment Targets and Body Composition | Doctor of Philosophy | Doctorate | Full Time | Prof Rob Venning Bryant |
| 2014 - 2016 | Principal Supervisor | Optimising Care for Patients with Inflammatory Bowel Disease: Rural Patients' Burden of Disease and Perceived Treatment Barriers: Outcomes of Transition Care and Evaluation of Simple Clinical Tools for Outpatient Management of Ulcerative Colitis | Master of Philosophy (Medical Science) | Master | Full Time | Mrs Alice Louise Nottle |
| 2013 - 2017 | Principal Supervisor | Issues in the Diagnosis and Management of Functional Gastrointestinal Disorders: The Development of a Novel Clinical Pathway | Doctor of Philosophy | Doctorate | Full Time | APrf Ecushla Claire Linedale |
| 2013 - 2019 | Principal Supervisor | Faecal Microbiota Transplantation for the Treatment of Active Ulcerative Colitis | Doctor of Philosophy | Doctorate | Full Time | APrf Samuel Paul Costello |
| 2012 - 2015 | Co-Supervisor | The progression and management of depression and anxiety in chronic hepatitis C patients | Doctor of Philosophy/Master of Psychology (Clinical) | Doctorate | Full Time | Mr Benjamin James Robert Stewart |
| 2012 - 2016 | Co-Supervisor | Three Studies Investigating Quality Indicators for the Treatment of Substance Use Disorders and Comorbidity: Continuity of Care, Treatment Need and Patient Satisfaction | Doctor of Philosophy/Master of Psychology (Clinical) | Doctorate | Full Time | Miss Stacey Lee McCallum |
| 2005 - 2008 | Co-Supervisor | Six Studies Pointing to the Need for a Biopsychosocial Approach to Treating Common Gastrointestinal and Hepatologic Disorders | Doctor of Philosophy | Doctorate | Full Time | Prof Antonina Mikocka-Walus |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2014 - ongoing | Board Member | Crohn's Colitis Cure | Charity | Australia |
| 2013 - ongoing | Advisory Board Member | Vedolizumab Australian Advicory Board | Vedolizumab | Australia |
| 2012 - 2013 | Advisory Board Member | Vital Foods Advisory Board | Vital Foods | - |
| 2011 - ongoing | Advisory Board Member | Remicade Advisory Board | Janssen | - |
| 2009 - ongoing | Advisory Board Member | Humira Advisory Board | Abbott & AbbVie | Australia |
| 2009 - ongoing | Advisory Board Member | IBD Advisory Board | Ferring | Australia |
| 2009 - 2011 | Advisory Board Member | Remicade Advisory Board | MSD | - |
| 2006 - 2009 | Advisory Board Member | Remicade Advisory Board | Schering Plough | - |
| 2005 - 2007 | Advisory Board Member | Colazide Advisory Board | Pharmacia Fresenius Kabi | Australia |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2008 - ongoing | Member | Research Ethics Committee | Royal Adelaide Hospital | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2013 - ongoing | Member | Australian Association of Consultant Physicians | - |
| 2008 - ongoing | Member | European Crohn's & Colitis Organisation (ECCO) | - |
| 2000 - ongoing | Member | American Gastroenterological Association | United States |
| 2000 - ongoing | Member | Australian IBD Association (within GESA) | - |
| 1994 - ongoing | Member | Royal Australasian College of Physicians | Australia |
| 1992 - ongoing | Member | Gastroenterological Society of Australia | - |
| 1986 - ongoing | Member | Australia Medical Association | - |
| Date | Office Name | Institution | Country |
|---|---|---|---|
| 2017 - 2019 | Chair SPC AGW 2018-2019 | GESA | Australia |
| 2017 - 2019 | Board Member GESA | GESA | Australia |
Connect With Me
External Profiles
